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ABSTRACT
The goal o f this work was to evaluate the feasibility o f using antimicrobial
peptide gene transfer to enhance oyster immunity. The specific objectives were to: 1)
compare the efficiency o f collagenase, pronase, and trypsin to dissociate atrium, ventricle
and mantle into individual cells for the initiation o f primary cell culture; 2) develop
cryopreservation conditions to preserve the dissociated cells; 3) establish a serum-free
transfection system; 4) evaluate inducible promoter function using the established serumfree transfection system; S) evaluate the effects o f the transfer o f antimicrobial peptide
genes on oyster immunity.
Pronase was found to be the most effective enzyme for dissociating the atrium,
ventricle, and mantle. Thereafter, pronase was used to dissociate atrium and ventricle
tissues for development o f cryopreservation conditions to preserve cells for culture.
Dimethyl sulfoxide, glycerol, and propylene glycol were evaluated for their
effectiveness as cryoprotectants. Freezing rates and thawing temperatures were
compared to minimize the damage. The optimal conditions were 10% glycerol, freezing
at a medium rate (vials containing cells were packed into a 21 x 1 9 x 7 cm and 0.7 cm
thick polystyrene foam box and with 80 g o f cotton followed by equilibration at 2S° C for
20 min, -80° C for 16 h, and -196° C for storage) and thawing at 45° C for atrial cells,
and 10% glycerol, freezing at a medium rate and thawing at 25° C for ventricle cells.
A serum-free transfection system for ventricle cells was established. A heat
inducible promoter was evaluated in the system. The optimal heat shock conditions for
the heat shock protein 70 promoter from snail, Biom phalaria glabrata, was 40° C for lh
followed by recovery at 25° C for 12 h. The induction o f the cecropin B promoter from

XUl
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moth, H yalophora cecropia, was evaluated in ventricle cells using lipopolysaccharide
and IL-1-alpha. In vivo transfer o f an antimicrobial peptide gene w as conducted.
Although not significantly different, oysters receiving the antimicrobial genes
controlled by the cecropin B promoter tended to have lower bacteria tissue loading than
the controls. The results o f this work implied that antimicrobial peptide gene transfer to
enhance oyster immunity is feasible.
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CHAPTER 1 INTRODUCTION
Goal and Objectives
Disease is a major hindrance in the development o f the oyster industry. The
hypothesis of this work was that the transfer o f an antimicrobial peptide gene to the
oyster could result in enhanced immunity to resolve the disease problem. The goal o f this
work was to evaluate the feasibility o f using antimicrobial peptide gene transfer to
enhance oyster immunity. The specific objectives were to: 1) compare the efficiency o f
collagenase, pronase, and trypsin to dissociate atrium, ventricle and mantle tissues into
individual cells for the initiation o f primary cell culture; 2) develop cryopreservation
conditions to preserve the dissociated cells; 3) establish a transfection system for the
dissociated ventricle cells which were cultured in serum-free medium; 4) evaluate
inducible promoter function using the established cell transfection system; 5) evaluate the
effects o f the transfer o f antimicrobial peptide genes on oyster immunity.

Production of Oysters
Oyster aquaculture is a commercially important industry in the United States,
generating a national dockside value o f over $100 million in 1995 (MacKenzie 1996a).
In 1997 oysters harvested from Louisiana contributed $50 million o f the national value
(Avery 1998). The eastern oyster, Crassostrea virginica, comprises 80% o f the United
States oyster harvest (Lorio and Malone 1994) and is a native species found along the
Atlantic coast o f North America from the Gulf o f St. Lawrence to the Gulf o f Mexico
where water temperatures range from 0° C to 30° C (GaltsofF 1964). The eastern oyster
is the major oyster species cultured in the United States (Wendell and Malone 1994).

1
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Oysters can reverse their gonad function from male to female, with gonads
maturing as males first, then changing to female the following year (Coe 1943). Mature
oysters for spawning can be collected from the wild during spawning months (June to
September in Louisiana) or year-round from laboratory conditioned (24° C) oysters.
Production o f seed oysters either collected from the wild, or artificially spawned and
fertilized in the hatchery is as follows: male and female ripe oysters are induced to spawn
in separate tanks either by shifting temperature from 21° C, to 28° C for 45 min or by
chemical stimulation such as 1 gM serotonin (5-hydroxytryptamine creatininesulfate
complex) (Gibbons and Castagna 1984). Alternatively, gametes can be stripped from
gonads for fertilization at a sperm to egg ratio o f 5,000:1 (Castagna and Kraeuter 1981).
At 24° C, fertilized eggs develop into embryos in 4 to 8 h, to the trochophore stage in 12
h, and to straight-hinge larvae in 24 h. Further development to eyed larvae (pediveligers)
occurs between 12 to 21 days. Then they metamorphose (change body shape) within 72
h, attach themselves to a substrate and form a shell. The later stage is called spat, which
can be seeded on sea grounds leased by farmers from the government. The spat will reach
maturity in 1 to 2 years (Galtsoff 1964).

Oyster Disease
Disease is one o f the major obstacles for the oyster industry. At least 45 oyster
diseases, for which the causative agents are either identified or unidentified, have been
reported. The main diseases associated with the eastern oyster and Pacific oysters, C.
gigas, are summarized in Table 1-1 (Bower et al. 1994). Causative agents include
viruses, bacteria, and protozoa. The most notorious disease threatening the culture o f the
eastern oyster is Dermo disease, which is caused by the protozoan parasite, Perkinsus
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Table 1-1. Major diseases associated with eastern oysters C rassostrea virginica (CV) and
pacific oysters C. gigas (CG).
Infected
Invaded tissue
Causative reagent
Disease
wecies*
Virus
Oyster velar virus
disease
Hemocytic infectious
virus disease

CG

Icosahedral DNA virus

Velar epithelium

CG

Icosahedral DNA virus

Hemocytes

CV

Papillomavirus-like
papovavirus

Gametes and gametogenic
epithelium

CG /C V

Herpes-type virus

Undefined

CG/CV

Rickettsialcs

Epithelial cells of gill and
digestive gland

CG

Nocardiasp.

Hinge ligament disease
o f juvenile oyster
Larval and juvenile
vibriosis
Protozoa
Dermo disease

CG/CV
CG/CV

Cytophaga-like
(gliding) bacteria
Vibrio sp.

Mantle, gill, adductor muscles
and heart
Hinge ligament

CG/CV

Perkinsus marinus

Oyster egg diseae

CG/CV

Protozoan

Seaside organism
(SSO)

CV

Haplosporidium costale

Multinuclcate sphere X
(MSX)
Aber disease

CV

Haplosporidium nelsoni

CG

Marieilia rejringens

Denman Island Disease
Gill trichodina
Larval mycosis

CV
CG
CV

Shell-burrowing
sponges
Oyster trematode
diseases

CG/CV

Mikrocytos mackini
Tricodina spp.
Sirolpidium
zoophthorum
Cliona spp.

Viral gametocytic
hypertrophy
Herpes-type virus
disease
Bacteria
Rickettsia-like and
Chlamydia-like
organisms of oysters
Nocardiosis

Unknown
Malpcque Disease

CG/CV

Gymnophalloides
toldensis,
Bucephalus spp.

CV

Unknown

Necrosis o f soft tissue
Inhibition o f growth,
development of gonads,
disruption o f connective tissue
Cytoplasm o f mature ova
Connective tissue of digestive
gland, gonads and mantle
Digestive epithelia
Tissue necrosis, cessation of
growth
Vesicular tissue necrosis
Erosion o f gill
Disintegration o f the soft tissues
Penetration of shell and formation
o f holes
Retardation of growth

Mantle recession and oedema
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m arinus, and results in an annual mortality o f 50% in G ulf Coast oysters (Craig et al.
1989). P. m arinus not only inhibits the growth o f oysters but also the development o f
gonads, and subsequently leads to a decrease in reproductive capacity (Kennedy and
Breisch 1981, Paynter and Burreson 1991).
The methods o f diagnosis, treatment, and prevention o f oyster diseasess are few.
The molecular diagnosis o f Haplosporodium nelsoni (Stokes and Burreson 1995), and P.
m arinus (Yaraall et al. 1997) uses the polymerase chain reaction, and the
immunodiagnosis o f protozoa (Mialhe et al. 1988, Boulo et al. 1989) and Vibrio spp.
(Noel et al. 1996) uses polyclonal and monoclonal antibodies. However, most other
diseases, such as viral diseases, require diagnostic methods that still rely on
morphological description and traditional histology. The lack o f cell lines and wellestablished cell culture conditions for the isolation o f pure vims further hinders studies o f
viral diseases at the molecular level. The control o f oyster diseases primarily relies on
management practices. Although treatment for bacterial diseases has been evaluated, it is
not practical for application in open-sea beds, and the induction o f antibiotic resistant
strains could result. Therefore, control strategies include quarantine, destruction o f vim s
infected oysters, and culturing oysters at low salinity and in low temperature areas to
reduce the prevalence o f P. m arinus or harvesting oysters early before the high mortality
o f P. m arinus infection occurs (Mackenzie 1996b).

Oyster Immunity
Oysters do not have adaptive immunity, characterized by specificity and memory
o f previous exposure to pathogens, but they do possess innate non-specific immunity.
The first line o f innate oyster defense against the invasion o f pathogens is the hard shell
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and mucus covering the soft body. The second line o f defense is the collaboration o f
cellular and humoral immunity. Immunologists currently use the term “cellular
immunity” to refer to the specificity o f immune responses of T lymphocytes and the term
“humoral immunity” to refer to the specificity o f antibody responses o f B lymphocytes.
However, oyster researchers and those who study more primitive animals such as
invertebrates still use the term “cellular immunity” to refer to non-specific immune
responses o f phagocytic cells and the term “humoral immunity” to refer to any effector
molecules in the circulation o f hemolymph. In this dissertation, the terms cellular
immunity and humoral immunity are used in the broad sense of the terms used for oysters
and invertebrates.
The limited knowledge of oyster immunity makes its study particularly
challenging. It requires an examination of the immune response o f closely related
bivalves and other mollusks and even further, references to unrelated invertebrates and
vertebrates. This makes the establishment o f universally accepted terminology more
critical and hopefully it will be addressed soon.

Cellular Immunity
Hemocytes: Oysters have an open circulatory system. The hemolymph (blood)
containing hemocytes circulates over tissues after passing out of arteries with open ends
and returns to the heart from a sinus. However, the hemopoietic tissues o f bivalves are
not known (Cheng 1981, Hine 1999). The classification o f oyster hemocytes relies on
morphology and is divided into two types: granulocytes and agranulocytes (Cheng 1981).
Both hemocyte types are active in phagocytosis o f small particles and encapsulation o f
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particles that are too large to be engulfed by a single cell, but granulocytes are the most
phagocytic cell type (Foley and Cheng 197S).
Phagocytosis: The most primitive mechanism o f cell defense is phagocytosis.
The attraction between oyster hemocytes and pathogens relies mainly on chemotatactic
molecules released from pathogens (Cheng and Howland 1979). Then, attachment
between pathogens and hemocytes can be enhanced (opsonized) by C a ^ (Renwrantz and
Stahmer 1983) and lectins, which reside in hemolymph or on the surface o f hemocytes
(Vasta et al. 1982). Thereafter, the pathogens are enclosed as membrane-bound vacuoles,
phagosomes, and fuse with lysosomes containing various enzymes and antimicrobial
factors (Cheng and Rodrick 197S).
Effector Molecules of the Hemocytes
Reactive oxygen intermediates (ROI): Once the pathogen is taken into the
lysosome, its elimination relies on the effector molecules o f the hemocyte. Phagocytosis
in molluscs is an oxygen consuming reaction. Bursts of respiratory activity during
phagocytosis generate reactive oxygen intermediates (ROI) including superoxide anions
(O2 ), hydroxyl radicals ('OH), singlet oxygen CO2 ), and hydrogen peroxide (H 2 O 2 )
(Adema et al. 1991). However, pathogens may not stimulate hemocytes to produce ROI.
For example, the ROI are not produced when live meronts, a multicellular stage in life
cycle o f P. m arinus, are phagocytized by eastern oyster hemocytes, but heat-killed P.
m arinus meronts stimulate the production o f ROI (La Peyre et al. 1992, 1995, Volety and
Chu 1995). Failure o f ROI generation after hemocyte phagocytosis o f P. m arinus may
contribute to the spread o f Dermo disease.
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Nitric oxide: Bivalve hemocytes also produce nitric oxide (NO) for generating
peroxynitrite anions (ONOO'), which are highly toxic in the presence o f superoxide
anions (Beckman and Koppenol 1996). The NO can be found in the hemocytes o f blue
mussels, M . edulis, and freshwater snails, Viviparus ater, (Conte and Ottaviani 199S) but
these compounds have not yet been identified in oysters.
Lysosomal enzymes: Other effector molecules in bivalve lysosome include
lysozyme, alkaline phosphatases, non-specific esterases, indoxyl esterase, betaglucuronidase, lipase, aminopeptidase, lysozyme and beta-hexosaminidase. Few studies
o f these enzymes have been conducted with the exception o f lysozyme (Cheng and
Rodrick 1975). Lysozyme is an enzyme that can digest the peptidoglycan layer o f
bacterial cell walls. The lysozyme o f oysters is similar to egg white lysozyme, which is a
15 kilodalton (KD) basic protein with the ability to lyse bacteria (Rodrick and Cheng
1974). The lysozyme concentration o f oysters is subject to seasonal variation and
inversely related to salinity (Chu and La Peyre 1993).
H um oral Im m unity
Lysosomal enzymes in hemolymph: circulation factors also play roles in
pathogen elimination. The release o f lysosomal enzymes such as acid phosphatase into
hemolymph is observed upon bacterial challenge in marine bivalves (Cheng and Buter
1979) but their regulation has not been identified.
Agglutinin: Agglutinins are non-immunoglobulin proteins containing 20 KD o f
identical subunits that can agglutinate particles such as bacteria ( Vibrio cholerae), by
binding specifically with sugar moieties on the particles (Acton et al. 1969). Agglutinins
can exist either free floating in the oyster hemolymph or associated with oyster
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hemocytes (Vasta et al. 1982). The main functions o f agglutinin are 1) immobilization
and inactivation o f pathogens to facilitate subsequent encapsulation, or extracellular
killing by other humoral factors, 2) as a mediator (opsonin) to facilitate phagocytosis, and
3) as self and non-self molecular recognition (Renwrantz and Stahmer 1983,
Mullainadhan and Renwrantz 1986). The agglutinin concentrations in the hemolymph o f
oysters challenged with P. marinus and H. nelsoni, and unchallenged oysters show no
difference implying that it was not induced (Chinatla et al. 1994).
Hem olysin: Circulation defense factors that can lyse red blood cells are referred
to as hemolysins. They were not found in oysters but are found in hemolymph and
hemocytes o f quahogs, M ercenaria m ercenaria, and blue mussels. Hemolysin is
inducible and requires calcium ions for function (Hardy et al. 1976, Feng and Baija
1986). Its role in bivalve humoral immunity is not known.
A ntim icrobial peptide: Antimicrobial peptides are found in invertebrates and
vertebrates. For molluscs, including sea hare, D olabella auricularia, (Kisugi et al. 1992),
Mediterranean mussel, M galloprovinciaiis, (Hubert et al. 1996a), blue mussel (Charlet
et al. 1996), and Pacific oyster (Hubert et al. 1996b), antimicrobial peptides are found in
hemocytes or hemolymph to protect from pathogen invasion. For example, defensin-1 of
Mediterranean mussel (MGD 1) is a 4 KD peptide containing 60 amino acid residues.
The granules o f hemocytes are the major sites where MGD 1 is found and released to the
hemolymph in response to bacterial challenge (Mitta et al. 1999).
Cytokine-like factor: Important effector molecules found in hemolymph o f
molluscs are cytokine-like factors (Table 1-2) (Clatworthy 1998) that can mediate and
regulate the immune response (Ottaviani and Franceschi 1997). These factors were
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Table 1-2. Cytokine-like molecules found in molluscs.
Molliiics

Cytoklae-like Molecules

Species

Mussel

Apfysia califomica

Interlukin-1-<IL-1)-beta, Tumor necrosis factor (TNF>alpha

Snail

Planorbarius comeus

IL-1-alpha, IL-1-beta, IL-2, IL-6, TNF-alpha

Snail
Snail
Mussel

Viviparus ater

IL-1-alpha, IL-l-beta, IL-2, IL-6, TNF-alpha
IL-1-beta, TNF-alpha
IL-1-alpha, IL-l-beta, IL-2, IL-6, TNF-alpha

Biomphalaria glabrata
Kfytilus edulis

produced from blue mussel hemocytes with antigenic stimuli such as LPS (Hughes et al.
1991). Although there is no direct evidence that bivalve cytokines participate in disease
resistance, the biological activities o f cytokines cross function among species. For
example, human IL-1 alpha and TNF-alpha induce similar morphological changes
(increase cell perimeter) in blue mussel granular hemocytes as seen in human
granulocytes (Hughes et al. 1990) and mammalian cytokines (IL-1 alpha, IL-1 beta, IL-2,
IL-6, and TNF-alpha) affect the cell mobility, phagocytosis, and induction o f nitric oxide
synthase o f hemocytes in snails (Planorbarius com eus and Viviparus a/er XOttaviani and
Franchini 1995). Conversely, IL-1 like-molecules are found in starfish, A sterias forbesi,
(Beck and Habicht 1991).

Enhanced Oyster Immunity by Transfer of Disease Resistance Genes
Although the eastern oyster possesses innate immunity as described above, these
effector molecules obviously are not enough to protect oysters from the invasion o f
certain fatal pathogens such as P. marinus. Because the eradication o f pathogens is not
possible, and quarantine and vaccines are not feasible to control oyster diseases,
introduction o f non-indigenous genes and genetic selection o f disease resistance strains
are two major strategies being evaluated to resolve oyster disease problems. Eastern
oyster culture could be replaced by culture o f the pacific oyster that is resistant to P.
m arinus (Barber and Mann 1994), but other pathogens such as herpes-like virus (Hine et
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ai. 1992, Le Deuff et al. 1996) are emerging to endanger hatchery-reared pacific oysters
(Table 1-1). In addition, induction o f exotic species may cause ecological impacts and
lead to the loss o f indigenous species. Therefore, it is not the best resolution for the
problem o f oyster diseases (Andrew 1980). Strains resistant to MSX have been
successfully developed by genetic selection, which is a passive, slow, and a less
controllable technique, the MSX resistance strains are still susceptible to other diseases
such as Dermo, and the specific disease resistance gene for MSX has not been identified
(Gaffney et al. 1996). In contrast to traditional genetic selection, genetic modification o f
oysters by transferring disease resistance genes is an active, fast, and more controllable
strategy to establish disease resistant strains.

Oyster Cell Culture
Cell culture has been long recognized as an important tool for cellular and
molecular studies. For example, the ability to isolate viruses in cell culture can enhance
disease diagnosis, while the pure virus obtained from cell culture can facilitate research
on further characterization o f the virus.
Vertebrate cell culture and cell lines are well established, but marine invertebrate cell
culture lags far behind (Rinkevich 1999). Although attempts to culture oyster cells were
successful with heart and mantle cells as early as 1960, further progress o f oyster cell
culture and establishment o f cell lines has been limited (Table l-3XChen and Wen 1999).
The major causes o f failure are attributed to the lack of systematic approaches and
inappropriately adopting vertebrate cell culture conditions (Bayne 1998). The efficiency
o f dissociation enzymes used to dissociate tissue has not been systematically compared.
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Table 1-3. Reports of culture conditions for oyster cells (after Chen and Wen 1999).
Species

Year

Tissues

Basal Medium

O strea edulis
Crassostrea
virginica
C. virginica
C. virginica

1960
1964

Heart and mantle
Mantle

Seawater
Blue crab plasma

1966
1966

Heart
Heart

C. virginica

1979

Heart

M199 and seawater
Scherer’s medium and
balanced salt solution
2 x M199

C. virginica

1979

Hemocyte

C. virginica

1981

C. virginica
C. virginica
C. virginica
C. virginica
C. gigas
O. edalis

1985
1987
1989
1992
1993
1995

Heart, gonad, mantle,
palp. Larvae, and
neoplastic hemocyte
Mantle and heart
Mantle and embryo
Embryo
Visceral ganglion
Heart
Heart

Minimum essential medium
(MEM)
NCTC-135, RPMI 1640, or
L-15
MEM
Ham’s F-12
Ham’s F-10
2 x L-15
2 x L-15
L-15 and seawater
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Therefore, Chapter 2 addresses the systematic comparison o f tissue dissociation
efficiency o f enzymes for culture in a medium optimized for oyster cells.
Cryopreservation o f vertebrate cells is an essential part o f cell culture to reduce
the cost and accidental loss o f cells, but no cryopreservation conditions have been
developed for oyster cells. Therefore, Chapter 3 addresses the development o f the first
cryopreservation conditions for oyster somatic cells.

Gene Transfer Methods
After the establishment of successful culture and cryopreservation procedures, a
gene delivery method must be determined and optimized to deliver candidate
antimicrobial peptide genes into cells for evaluation. Methods used to deliver genes can
be categorized into biological, physical, and chemical methods.
One o f the most often used biological methods is the use o f viruses as a vector to
deliver target genes into host cells. The virus genome is modified to reduce the
generation o f toxic proteins, the transformation o f cells into malignant cells, and the
induction o f host immune responses to the transformed cells. The advantage o f using
viruses as a vector to deliver genes is, that target genes carried in a viral genome can be
carried to the nucleus for expression. However, without receptor modification, virus host
specificity may limit this use to certain animals.
Retroviruses and adenoviruses are often used to deliver genes into cells. The
advantages o f using a retrovirus, which is an RNA virus, are: 1) stable integration into
host genome, 2) insertion capacity of a gene up to 10 kb, and 3) broad host range. The
disadvantages are: 1) the requirement o f proliferating host cells for virus to integrate, 2)
the difficulty o f producing highly infective viruses, 3) possible mutation o f viruses
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thereby causing disease (Cournoyer and Caskey 1993, Gilboa 1990). Retroviruses have
been used in the production o f transgenic aquatic animals, including dwarf surfclam,
M ulinia lateralis, (Lu et al. 1996), zebrafish, Danio rerio, (Lin et al. 1994), and medaka,
O ryzias latipes, (Lu et al. 1997). The major advantage o f using an adenovirus, which is a
double-strand DNA virus, is that proliferating and non-proliferating cells can be infected.
The disadvantages are: 1) non-integration and, 2) causing host humoral and cellular
immune responses to virus and transfected tissues (Yei et al. 1994, Yang et al. 199S).
Sperm is a biological method to deliver target genes into oocytes. The uptake o f
foreign DNA was first found with rabbit sperm in 1971 (Brackett et al. 1971). It has been
used to deliver target genes into aquatic animal oocytes including sea urchins,
Paracentrotus lividus, (Arezzo 1989), Japanese abalone, H aliotis divorsicolor, (Tsai et al.
1997), and several fish species (Muller et al. 1992).
Physical methods to deliver genes into cells include microinjection,
electroporation, and particle bombardment (gene gun). Microinjection, which is directly
injecting the gene through a needle into the nucleus, is time consuming, but a transgene
can be precisely located into cells for expression. It has been widely using in producing
transgenic mammalian animals such as mice (Landel 1991) and aquatic animals including
fish (Inoue 1992) and pacific oyster (Cadoret et al. 1997). Electroporation uses an
intensive electric field to make transient pores in the cell membrane allowing
macromolecules to enter or exit the cells (Benz and Zimmermann 1981). The advantages
o f electroporation are simplicity, and the large numbers o f cells that can be processed at
one time. The disadvantages are the requirement o f large amounts o f DNA and that it is
difficult to perform on internal tissues. It has been widely applied to cells including
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yeast, fungi, protozoa, algae (Shigekawa and Dower 1988, Weaver 1995), and medaka
(Inoue et al. 1990), and red abalone, H aliotis rufescens, (Powers et al. 1995). The gene
gun uses high velocity DNA-coated microparticles driven by high-pressure gas to deliver
DNA into cells (Yang et al. 1990). Genes can be delivered into most cell types but the
coating o f particles (usually gold) is expensive. Transgenic fish (Zelenin et al. 1991), and
brine shrimp (Artem ia) (Gendreau et al. 1995) were produced using a gene gun to deliver
genes into cells.
Chemical methods basically rely on the positive charge (cationic) o f a chemical
reagent forming a DNA-reagent complex to aid DNA delivery. Cationic lipid-based
liposome reagents are most often used. The reagents possess polar and non-poiar groups
o f molecules that can self-assemble to form liposomes in a solvent. The liposome has a
structure similar to the lipid bilayer structure o f cell membranes to aid gene delivery
(Nicolau and Cudd 1989).
Cationic lipid-based transfection reagents are biodegradable, highly efficient gene
delivery vehicles with low toxicity. However, not every cell type can be transfected.
Screening proper transfection reagents and optimizing the transfection conditions are
required for each specific cell type.
In summary, each gene delivery method has its advantages and disadvantages.
For the development o f an oyster in vitro gene transfer system, a lipid-based reagent was
chosen to deliver genes into oyster cells due to the high efficiency of transfection and
ease of preparation. Therefore, the first part o f Chapter 4, addresses the optimization o f
transfection conditions using a lipid-based transfection reagent.
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Promoter to Control the Expression of a Disease Resistance Genes
Although all the effector molecule genes o f immunity can be considered for transfer to
enhance oyster disease resistance, antimicrobial peptide genes may have the most
potential. Because antimicrobial peptides are nonspecific effector molecules, the
antimicrobial peptide genes must be expressed in an inducible way to prevent over
expression and damage to host cells.
Gene expression can be regulated at the level o f gene transcription, RNA
processing, transportation of mRNA from nucleus to cytoplasm, mRNA translation,
mRNA stability, and post-translation (Darnell 1982). However, gene regulation is mainly
controlled at the transcriptional level by the promoter. The promoter is a segment of
DNA to which RNA polymerase and general transcription factors bind, to initiate
transcription. Two consensus sequences are found in the promoter region o f most genes.
The TATA box (consensus sequence o f 5’-TATAAAA-3’) centers around position - 25,
i.e. 25 nucleotides upstream from the transcription start nucleotide (+1). The CAAT box
(consensus sequence o f 5’-GGCCAATCT-3’) centers around position +90 (Breathnach
and Chambon 1981). Specific gene regulatory proteins (transcription factors) bind to
specific sequences around the promoter region to regulate (inhibit, induce or enhance)
gene transcription (Atchison et al. 1988). The presence of specific DNA sequences
around a promoter region implies that the gene can be regulated by the transcription
factors that bind to those sequences. In addition, the transcription efficiency o f a gene
can be facilitated by enhancers, which are DNA sequences that can function regardless o f
orientation and distance from a promoter (Ptashne and Gann 1990). Moreover, the non-

15

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

coding DNA sequence (intron) intervening between DNA coding sequences (exons)
affects promoter activity. For example, the human beta-globin gene fails to produce
stable transcription in erythrocytes unless the intron is included in the transcription unit
(C ollisetal. 1990).
Because gene expression is mainly controlled at the transcriptional level by the
promoter, the selection o f an inducible promoter is critical to drive the expression o f an
antimicrobial gene. Therefore, the second part o f Chapter 4 addresses the evaluation o f
inducible promoters to control gene expression in vitro. Chapter S addresses the
feasibility o f gene transfer to enhance oyster disease resistance. Finally, the overall
results are summarized in Chapter 6 . The chapters were prepared in journal format and
modified to dissertation style according to CBE Style M anual (Council o f Biology Editors
1994).
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CHAPTER 2 COMPARISON OF EASTERN OYSTER TISSUE DISSOCIATION
USING COLLAGENASE, PRONASE AND TRYPSIN
Introduction
The eastern oyster, Crassostrea virginica, o f the Gulf o f Mexico and eastern coast
of the United States, has been plagued by the widely epidemic and fatal disease Dermo,
caused by an intracellular parasite Perkinsus m arinus (Andrews 1988, Craig et al. 1989).
In hatcheries, mortality associated with a virus was found in larvae o f the pacific oyster
Crassostrea giga (Hine et al. 1992), and unknown agents have caused high mortality in
spat o f the eastern oyster (Small 1997). Although final resolution o f these diseases may
rely on in vivo genetic selection, gene transfer, chemotherapeutants, or modified culture
practices, an in vitro cell culture system would facilitate and expedite disease research at
the cellular and molecular level. Because no transformed cell lines are available for
oysters, primary cultures have been used in the study o f cell interactions between
pathogen, host (Mourton et al. 1992, Ford and Alcox 1993), and gene function (Boulo et
al. 1996).
Isolation o f cells is the first and most important step for initiating primary cell
culture and establishing a cell line. Viability, cell yield, and functional integrity o f isolated
cells need to be maximized during the process. Physical methods, chemical methods, or a
combination o f both have been used to isolate cells (Freshney 1994). Physical methods,
including scraping, rubbing, and agitation (Momtazi and Herbert 1973), are used to break
tissues into individual cells or to mince tissues into

1

to

2

mm3 explants, from which

individual cells can migrate. Chemical methods involve the addition o f chelating agents,
such as ethylenediaminetetraacetic acid (EDTA), to deplete divalent ions, which are
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essential for adhesion between cells, and the addition o f proteolytic enzymes, to digest
extracellular matrices (Freshney 1994). Currently, tissue explant and enzyme dissociation
are the two major methods used to isolate oyster cells for primary cell culture. Enzyme
dissociation provides large amounts o f different cell types immediately after dissociation,
while tissue explants provide only a few cells after 7 to 14 days (d) o f culture and yield
only specific cell types that are able to migrate from the explant. For example,
granulocytic hemocytes are the main cell type observed after 7 to 10 d using heart
explants, while hemocytes, pigment cells, fibroblast-like cells and cardiomyocytes are the
main cell types elicited from enzyme dissociation o f heart cells (Wen et al. 1993, Le Deuff
et al. 1994). The cell types derived from enzyme dissociation can enhance studies o f the
oyster immune system (Renault et al. 1995).
Enzymes, often used in dissociation o f vertebrate tissues, have been used to
dissociate oyster tissues. Pronase, trypsin, and collagenase were used to dissociate heart
cells o f the eastern oyster, and collagenase was more efficient than others in viable cells
yields (Brewster and Nicholson 1979). Trypsin was effective in dissociating heart but not
the mantle o f eastern oyster (Hetrick et al. 1981). Collagenase and pronase were more
efficient than trypsin for dissociating heart cells o f the pacific oysters in terms o f viable
cells and cell attachment (Wen et al. 1993). Pronase was used to dissociate heart cells of
pacific oysters and those cells possessed the ability to express a heat shock inducible
transgene after dissociation (Boulo et al. 1996). Trypsin was used to dissociate heart cells
o f eastern oyster, pacific oyster and European flat oyster Ostrea edulis, for culture (Sami
et al. 1991, Le Deuff et al. 1994, Renault et al. 1995).
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The reports on the effectiveness o f these enzymes varied, and no systematic
comparison and statistical analyses were reported. The goal o f this research was to
systematically compare the efficiency o f collagenase, pronase, and trypsin in dissociating
atrium, ventricle, and mantle o f the eastern oyster. The objectives were to: 1) dissociate
atrium, ventricle, and mantle using collagenase, pronase, and trypsin and 2 ) compare total
cell number, cell yield, viability, viable cell yield and the dehydrogenase activity o f
dissociated cells o f each tissues.

Materials and Methods
Oyster Depuration and Tissue Decontamination
Eastern oysters, 9 to 10 cm in length, were obtained from reefs near Grand Isle,
Louisiana. The shell surfaces were scrubbed vigorously with a 5% solution o f ChloroxR
(5.25% sodium hypochlorite by weight), rinsed with fresh water, and maintained in a
recirculating system with ultraviolet-treated artificial seawater (15%o salinity, 25° CXFritz
Super Salt, Friz Industries Inc. Dallas, Texas). Oysters were held without feeding one
week prior to dissociation experiments to reduce microorganism loads (Hetrick et al.
1981).
Thirty oysters were opened. The oyster heart is located at the left side o f the
adductor muscle and is covered by a pericardial membrane (Appendix E). Thirty atria, 10
ventricles and 3 mantles were dissected, and washed three times with 50 ml o f 0.45-pm
membrane-filtered (Nalgene, Rochester, New York) artificial sea water (FASW). Each
tissue type was transferred to 50-ml tubes containing 10 ml o f decontamination solution
(Appendix A ), and the tubes were incubated 30 min at room temperature on a rocking
platform (3 cycles/min) to reduce microorganism contamination (Hetrick and Stephens
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1979, La Peyre et al. 1993). Decontaminated tissues were centrifuged at 200 X g for 3
min to remove FASW from the tissues. The SW was discarded and the tissues were
weighed. The tissues were minced into 1 to 2 mm3 pieces to facilitate cell dissociation.

Selection of Dissociation Enzymes and Solutions
The enzymes, collagenase (type XI, Sigma Chemical Corp, St. Louis, Missouri),
trypsin (Sigma), and pronase (CalBiochem, La Jolla, California) were used because they
contain other proteases or nonspecific enzymes that can facilitate digestion o f cell matrices
and cell junction proteins to release single cells. Collagenase type XI was used because it
has higher collagenase and nonspecific neutral protease activity than other types. Saline
solutions (saline I and saline EXAppendix B ) rather than culture medium were used as a
dissociation solution to simplify conditions. Collagenase and pronase require divalent
cations to function (Bond and Wart 1984, Narahashi et al. 1968), therefore saline I, which
contains calcium and magnesium was used. Trypsin does not need divalent cations to
function, so saline II was used. For facilitating cell dissociation, EDTA was added to
saline II to deplete divalent cations, which are essential for cell-to-cell adhesion. The
carbohydrates in saline II were used to prevent the re-aggregation o f the dissociated cells
and to enhance yields (Farris 1968).
Tissue Dissociation
Enzyme dissociation combined with physical agitation was chosen for the isolation
o f oyster cells, which are needed in large numbers for the establishment o f cell lines and in
vitro studies. Each type o f minced tissue was equally divided into four 30-ml beakers,
labeled A, B, C, and D. Saline I (9 ml) was added to beakers A, B, and C and saline II (9
ml) was added to beaker D. Thereafter, 1 ml o f the following reagents was added for a
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total volume o f 10 ml in each beaker: saline I for beaker A (control), collagenase (750 U/
ml, Sigma) for beaker B, pronase (450 U/ml, CalBiochem, La Jolla, California) for beaker
C, and trypsin-EDTA (5000 U/ml trypsin, 0.2% EDTA w/v, Sigma) for beaker D. The
beakers were placed on a stir plate (Model Nuova D, Thermolyne Corporation, Dubuque,
Iowa) and octagonal stir bars

(8

mm diameter x 12 mm long) were used to agitate the

solution at 700 revolutions per minute (rpm) during dissociation. Tissues were dissociated
for 60 min at 25° C, except for the trypsin-treated tissue, which was dissociated for 30
min. One ml o f fetal bovine serum (FBS, Sigma) was added to beaker D to inactivate
trypsin after dissociation. Any undissociated tissue was separated from dissociated cells in
10-ml conical tubes by centrifugation (Model TJ- 6 centrifuge, Beckman, Palo Alto,
California) at 20 x g for 3 min. The supernatants containing dissociated cells were
transferred to

10

-ml conical tubes and the undissociated tissue pellets were discarded.

Dissociation enzymes were eliminated by centrifugation at 200 x g for 10 min, and the
supernatants were discarded. These cell pellets were resuspended in saline II.
Centrifugation and re-suspension o f the pellets in saline II was repeated twice. Finally, the
cell pellets were suspended in JL-ODRP-4 culture medium (Appendix CXLa Peyre et al.
1993) with 10% FBS forevaluation.
Evaluation Parameters
Total cell number, cell yield, cell viability, viable cell yield and dehydrogenase
activity were evaluated. Total cell number was counted with a hemocytometer at 100 x
magnification using phase-contrast microscopy (Optiphot-2, Nikon, Garden City, New
York) and cell yield was calculated (total cell number divided by tissue weight). Cell
viability was evaluated using a dye exclusion assay using trypan blue (Phillips 1973) and a
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LIVE/DEAD® Assay Kit (Molecular Probes, Eugene, Oregon) that uses fluorescent dyes
to indicate viability and cytotoxicity (referred to as fluorescent dye assay in this paper).
Viable cell yield was calculated by multiplying cell viability and cell yield. The
dehydrogenase activity was measured using a Cell Titer 96™ kit (Promega, Madison,
Wisconsin) and the manufacturer’s suggested protocol. This is a cell proliferation assay
that is aqueous and non-radioactive.

Data Analysis
Tissue dissociation was repeated five times. Due to variability during each
dissociation, data were analyzed using a randomized block design and one-factor analysis
o f variance (ANOVA). Duncan’s multiple range test was performed when significant
differences were found (P < 0.05).

Results
For atrial tissues, pronase treatment produced significantly higher (P < 0.05) total
cell numbers (13.8 ± 7.1x 106 cells, n = 10) and cell yields (170.9 ± 52.2 x 107 cell/g
tissue) than did other treatments (Figure 2-1). No significant difference (P > 0.05) was
found among tissues treated with collagenase, trypsin, and the control. Regardless o f the
method used, the pronase-dissociated cells had significantly higher viability (92 ± 4 % for
the trypan blue assay, 89 ± 5% for fluorescent dyes assay) than did cells dissociated with
collagenase, trypsin, or the control (Figure 2-2). Trypsin-dissociated cells had
significantly higher viability (P < 0.05) than collagenase dissociated cells in a trypan blue
dye assay (87 ± 3% vs. 85 ± 3%) and dehydrogenase activity assays (44.0 ± 11.35 x 10'3
vs. 32.2 ± 4.9 x 103). Pronase-treated tissues also had a significantly higher viable cell
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yield (156.7 ± 45.6 x 106 cell/g tissue for the tiypan blue assay, 149.8 x 10* ± 40.5 cell/g
tissue for the fluorescent dye assay (Figure 2-3), and dehydrogenase activity
(62.0 x

1 0 '3

+ 7.9 A4 9 0 M1) than did other treatments (Figure 2-4).

For ventricle tissues, pronase treatment produced a significantly higher (P < 0.05)
total cell number (11.0 ± 3.5x 106 cells) and cell yield (103.9 ± 30.7 x 107 cell/g tissue)
than did other treatments (Figure 2-1). In viability assays, no significant difference
(P > 0.05) was found between pronase-dissociated cells and collagenase-dissociated cells
in a trypan blue dye assay (93% vs. 89%) and fluorescent dye assay (91% vs.

88

%)

(Figure 2-2) but in terms o f viable cell yield, pronase-dissociated tissues generated a
significantly higher yield (96.4 x 106 ± 27.9 cell/g tissue for trypan blue assay, 94.7 ± 27.9
x

106

cell/g tissue for fluorescent dye assay) than did collagenase-dissociated tissues,

trypsin-dissociated tissues and control tissues, regardless o f the assay method used (Figure
2-3). In the dehydrogenase activity assay, pronase-dissociated cells showed a significantly
higher dehydrogenase activity (92.5 ± 51.1 x 10' 3 A4 9 0 an) than did other treatments
(Figure 2-4).
For mantle tissues, pronase treatment generated significantly higher total cell
numbers (12.8 ± 7.0 x 106 cells) than did other treatments, but in terms o f cell yield, no
significant difference was found between pronase-dissociated tissues and collagenasedissociated tissues (46.2 ± 13.2 x 107 cell/g vs. 38.2 x 107 ± 21.8 cell/gXFigure 2-1). A
significantly higher viability was found in pronase-dissociated cells (90% for trypan blue
assay;

88

% for fluorescent dye assayXFigure 2-2). Meanwhile, a significantly higher

viable cell yield was found in pronase-dissociated tissues (41.2 ± 12.4 x 106 cell/g for
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letters (A, B, and C) were not significantly different (P > 0.05).
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Figure 2-4. Dehydrogenase activity o f enzyme-dissociated oyster tissues (n = 5 for each
treatment). Controls were dissociated without enzyme. Means of each tissue sharing
letters (A, B, C, and D) were not significantly different (P > O.OS).
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trypan blue assay, 40.4 ± 11.62 x 106 cell/g for fluorescent dye assayXFigure 2-3). A
significantly higher dehydrogenase activity was found in pronase-dissociated cells
(93.7± 33.10 x 10*3 A 4 9 0 a^XFigure 2-4). Although trypsin-dissociated cells showed
significantly higher viability than collagenase-dissociated cells in the trypan blue assay (85
% vs. 81%) and dehydrogenase activity (81.5 ± 33.0 x

10~3

vs. 69.9 ± 24.6 x

1 0 -3

A4 9 0 ».),

collagenase-treated cells had a significantly higher viable cell yield than trypsin-treated
cells.

Discussion
Although oyster tissues have been routinely dissociated with enzymes for in vitro
studies and attempts have been made to establish cell lines, the most effective dissociation
enzymes have not been previously identified due to a lack o f systematic comparison and
the evaluation o f statistical data. This study represents the first systematic approach and
statistical analysis o f enzymatic-dissociated cells from atrium, ventricle, and mantle o f the
eastern oyster.
The dissociation efficiency o f pronase has been suggested to be less than that o f
collagenase in dissociating heart cells o f eastern oysters (Brewster and Nicholson 1979),
but pronases can effectively liquefy mucins, which are the main component o f mucus.
Pronase has been used successfully to isolate feline goblet cells from mucus-rich trachea
(Sherman et al. 1988) and rat gastric mucosal cells from the stomach (Kurokawa et al.
1975) while maintaining cell morphology, viability, and functional integrity o f the mucous
secretion. Therefore, pronase would be expected to be more efficient than collagenase or
trypsin in dissociating mantle tissues, which are high in mucin content. Surprisingly, not
only pronase-treated mantle, but also pronase-treated ventricle and atrium, generated
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significantly higher viable cell yields and dehydrogenase activity. This suggests that
oyster extracellular proteins and compounds are susceptible to pronase, and that other
tissues may be dissociated effectively by pronase.
Because one o f the major extracellular proteins in multicellular animals is collagen,
collagenase is widely used to dissociate vertebrate tissues (Burgeson 1988). Collagenase
has been suggested to be a more efficient enzyme than trypsin for dissociating heart cells
o f eastern oyster and Pacific oyster (Brewster and Nicholson 1979, Wen et al. 1993) but
we found that collagenase is much less efficient than trypsin and pronase.
During dissociation, trypsin-treated atrial and ventricle tissues were aggregated
with viscous materials. This may be due to the release o f nucleic acids from lysed cells.
Addition o f deoxyribonuclease, or reducing the trypsin concentration, or incubation time
may further improve the dissociation efficiency o f trypsin. Regardless o f the enzyme used,
cell yields from mantle were lower than atrium, ventricle, and undissociated mantle tissues
remained intact without viscous materials. This implied that mantle was not as susceptible
as atrial and ventricle tissues to collagenase, pronase, and trypsin. Using a combination o f
pronase with other dissociation enzymes may increase the cell yield from mantle.
Unexpectedly, the control in atrium and ventricle dissociation showed no
significant difference in total cell number, cell yield and viable cell yield when compared to
samples treated with collagenase and trypsin. This indicates that if the dissociated cell
yield and viability were not the main objective, oyster heart could be dissociated by
mechanical agitation. These cells could then be used in studies without protease
interference.
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In the present study, trypan blue dye exclusion and fluorescent dye assays were
used to evaluate cell viability. Dye exclusion using trypan blue tended to indicate higher
viability but significant differences in values were not found between trypan blue dye and
fluorescent dye assays. In the fluorescent dye assay, calcein was used to identify live cells
and ethidium homodimer-1 (EthD- 1 ) was used to identify dead cells. It appeared that
EthD-1 could be used alone like trypan blue. The principle o f EthD-1 entry into cells, is
the same as that for trypan blue, but EthD-1 stains nucleic acids in the nucleus and with
40-fold increases in red fluorescence, which can be observed by fluorescent microscopy.
The strong red fluorescence o f EthD-1 stained cells can be distinguished more easily than
the trypan blue-stained cells that may be obscured by stained extracellular proteins.
Therefore, we concluded that viability evaluation using EthD-1 alone is easier, more
accurate and more efficient than evaluation using trypan blue.
In conclusion, this is the first report o f a quantitative comparison o f enzymatic cell
dissociation in oysters, and demonstration that pronase was the most efficient enzyme for
dissociating atria, ventricle, and mantle tissues into single cells when measured by viable
cell yield and dehydrogenase activity. Further optimization o f dissociation efficiency may
be achieved by using combinations of more than one enzyme. In our laboratory, pronaseisolated oyster cells are used for the development o f a chemically defined medium, testing
o f lytic peptide toxicity, optimization of attachment factors, and transgene expression
studies.
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CHAPTER 3 CRYOPRESERVATION OF HEART CELLS FROM THE
EASTERN OYSTER
Introduction
Cryopreservation o f cells is defined as maintenance at ultra-low temperatures to inhibit
biological, chemical, and physiological processes o f the cells (Karlsson and Toner 1996).
Usually, cells are put into vials and stored in liquid nitrogen or above it, in the vapor
phase. Major stresses such as the chemical and physical effects o f ice crystals and
osmotic shock can damage cells during freezing and thawing. However, these effects can
be reduced by controlling the freezing rate, thawing rate, and by addition o f chemicals
such as dimethyl sulfoxide (DMSOXLovelock and Bishop 1959) and glycerol (Leueng
1991) as cryoprotectants to modify intracellular and intercellular environments.
Cryopreservation has been used to store vertebrate cells to provide a constant source o f
cells for culture (Freshney 1994), and in addition, has the following advantages: 1 ) it is
less expensive than maintaining live animals; 2 ) it minimizes the cost o f cell culture
maintenance; 3) it lowers the risk o f viral, bacterial, and fungal contamination or
accidental loss; 4) it reduces cell aging and genetic changes; and 5) it increases the ease
o f shipping to other laboratories. As a result, cryopreservation has become an
indispensable tool for cell culture.
Cell culture is valuable for numerous in vitro studies. Cells can come from frozen
cell lines (immortal lines) or freshly dissociated tissues (primary culture). Currently, an
immortal oyster cell line is not available (McGladdery 1998). Primary cultures are the
only cell source for in vitro studies. For instance, primary heart cell culture was used to
study the function o f the D rososphila heat shock gene promoter in oysters (Boulo et al.
1996) and hemocytes were used to study interactions with parasites (Ford et al. 1993,
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Mourton et al. 1992). Unfortunately, with the exception o f peripheral hemocytes, oyster
primary cell cultures are obtained with a time-consuming (7 to 14 d) tissue explant
culture method (Stephens and Hetrick 1979) or a labor-intensive enzyme digestion
method (Renault et al. 1995). Moreover, oysters are filter feeders, accumulating large
numbers o f microorganisms, especially in the summer Thus contamination is a major
obstacle during cell isolation and culture. Although primary cultures o f oyster heart cells
and hemocytes (Wen et al. 1993, Stephens and Hetrick 1979) can be maintained for 1 to 6
months, the cost o f culture maintenance is high, as is the risk o f cell loss. Meanwhile,
cell aging and genetic changes can interfere with research results. All o f these problems
make the establishment and use o f primary cell cultures uncertain. Cryopreservation o f
cells can minimize these obstacles.
Cryopreservation conditions have been developed for bivalve germ line cells
such as sperm and oocytes of the pacific oyster, Crassostrea gigas, (Yankson and Moyse
1991, Naidenko 1997). Cryopreservation conditions for embryos of, C. gigas, (Gwo
1995), hard clam, M eretrix lusoria, (Chao et al. 1997) and eastern oyster, C. virginica,
(Paniagua et al. 1998) were established. For dissociated cells such as the mantle and the
gill of mussel, M ytilus trossulus, digestive gland cells o f the scallop, M izuchopeclen
yessoensis, (Odintsova and Tsai 1995) and heart o f the scallop, P ecten maximus, (Le
Marrec-Croq et al. 1998), cryopreservation conditions were also reported. However,
effective cryopreservation conditions vary with each species, cell type, and
developmental stage. Cryopreservation conditions for dissociated oyster cells have not
been reported. The goal o f this work was to develop cryopreservation conditions for
oyster heart cells, which are considered to be the best tissue for in vitro studies (Chen and
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Wen 1999). The objectives were to compare the effects of: 1) cryoprotectant type and
concentration; 2) freezing rate; 3) thawing rate; and 4) each cryoprotectant on
cryopreservation of pronase-dissociated atrial and ventricle cells o f the eastern oyster.

Materials and Methods
Oyster Depuration
Oysters were collected at Grand Isle, Louisiana and maintained at the Department
o f Veterinary Science, Louisiana State University Agricultural Center, in a recirculating
system containing ultraviolet-light treated 20 %o, 25° C artificial seawater (ASW) that
was prepared using Instant Ocean9 salts (Aquarium Systems, Mentor, Ohio). Oysters
were kept in the tank at for at least

1

week without being fed, to reduce the bacterial load.

Tissue Dissection and Decontamination
The oyster heart is located at the left side of the adductor muscle and is covered
by a pericardial membrane (Appendix E). Ventricles and atria o f 30 oysters were
dissected and washed three times with 30 ml o f ASW, which was filtered (FASW) with a
0.22-yim pore size membrane (Nalgene International, Rochester, New York). All
chemicals were reagent grade and were purchased from Sigma Chemical Company (St.
Louis, Missouri) unless otherwise indicated. Tissues were decontaminated as described
in Chapter 2)

Tissue Dissociation
Ventricles and atria were dissociated separately in SO ml beakers containing 30 ml
o f saline I (Appendix B) containing 45 U pronase/ml (Calbiochem, La Jolla, California)
for 60 min. The beakers were placed on a stir plate (Model Nuova II, Thermolyne
Corporation, Dubuque, Iowa) and octagonal stir bars ( 8 mm diameter x 12 mm long)
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were used to agitate the solution at 700 revolutions per minute during dissociation. Any
undissociated tissue was separated from cells in 50-ml conical tubes by centrifugation
(Model TJ-6 centrifuge, Beckman, Palo Alto, California) at 20 x g for 3 min. The
supernatants containing dissociated cells were transferred to 50-ml conical tubes and the
undissociated tissue pellets were discarded. To remove pronase, the cells were pelleted
by centrifugation at 200 x g for 10 min. The supernatants were discarded and cells were
resuspended in 30 ml o f saline II (Appendix B); this was repeated twice. After the last
centrifugation, the cell pellets were resuspended in 10 ml o f freezing medium, which
contained JL-OPRD-4 medium (La Peyre et al. 1993) without antibiotics and with 20%
(v/v) fetal bovine serum (FBS) and a cryoprotectant additive (refer to Study 1 below).
Cell numbers were counted with a hemocytometer (Freshney 1994) and the cell density
was adjusted to 5 x 106 cell/ml in the same freezing medium used for suspension and
counting.

Study 1: Comparison of Cryoprotectants and Concentrations
The effects o f dimethyl sulfoxide (DMSO), glycerol, and propylene glycol (PG)
on dehydrogenase activity and cell spreading o f atrial and ventricle cells were evaluated
at 5%, 10% and 15% final concentrations. All procedures before freezing at -80° C were
performed at 25° C unless otherwise indicated. Each treatment had 3 replicates and
medium containing no cryoprotectant was used as a control. Based on preliminary
studies o f determining the initial freezing rate, the cryopreservation conditions were
defined in three comprehensive steps:

I)

Addition of cryoprotectants and cell freezing: An equal volume o f atrial or

ventricle cells at 5 x 106 cell/ml and freezing medium containing a 2 X final
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concentration o f cryoprotectant were mixed. The mixture was distributed into 2-ml
cryovials (Sarstedt, Leicester, United Kingdoms) in 700 pi aliquots for freezing.
Cryovials containing atrial cells were packed into a 21 x 19 x 7 cm and 0.7 cm thick
polystyrene foam box and wrapped with 2 layers o f cotton (80 g/layer). Cryovials
containing ventricle cells were packed into a polystyrene foam box without additional
wrapping. Atrial and ventricle cells were equilibrated at 25° C for 20 min, at >80° C for
16 h, and plunged into liquid nitrogen (-196° C) for storage.
2) Cell thawing and cryoprotectant removal: After 3 d o f storage, cells in
individual cryovials were thawed in a 45° C water bath with shaking until all ice crystals
had melted (~ 1 min). The thawed cell suspension was gently transferred to a 15-ml
conical tube. Culture medium was added drop-by-drop, over 20 min until the freezing
medium was diluted 10 folds, and the cells were pelleted by centrifugation at 4° C at 200
x g for 10 min. The supernatants were discarded and the cells resuspended in 700 pJ o f
culture medium and seeded for culture at a volume o f 100 pl/well in a 96-well plate
(Falcon Plastics, Becton Dickinson Inc., Franklin Lakes, New Jersey).

3) Evaluation of dehydrogenase activity and extent of cell spreading: Cells
w ere cultured for 3 d at 25° C. Dehydrogenase activity o f mitochondria was used as an
index o f cell viability (Mosmann 1983). The dehydrogenase activity (absorbance at 490
nm, A490) was assessed using a Cell Titer 96™ aqueous non-radioactive cell proliferation

assay kit (Promega, Madison, Wisconsin) following the manufacturer’s protocol.
With a phase-contrast inverted microscope (Diaphot-TMD, Nikon, Garden City,
New York) at 400X magnification, the extent o f cell spreading was ranked. Cells that
were flattened and extended were counted as “spread.” The ratio o f the num ber o f spread
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cells to total cell numbers from at least 300 cells was calculated as the percentage o f cell
spreading. The control that received no cryoprotectant and no freezing or thawing was
ranked as the highest (100%) extent o f cell spreading with “ m m .” By comparing with
the control, the extent of cell spreading o f other treatments were ranked as “+” (< 25%),
“++” (> 25% but < 50%), “+++” (> 50% but < 75%), or “++++” (> 75%). The highest
cell dehydrogenase activity and level o f cell spreading for each treatment in the same
cryoprotectant were used as criteria for selection of conditions for subsequent studies.
S tudy 2: Comparison of Thawing Temperature
The most effective concentration o f each cryoprotectant in Study 1 was adopted
for comparison o f thawing temperatures for atrial and ventricle cells. Cryopreservation
conditions and evaluation criteria were the same as in Study 1 except that thawing
temperatures o f 25° C, 45° C, and 70° C, were tested.

Study 3: Comparison of Freezing Rates
For further optimization o f cryopreservation conditions, freezing rates were
compared. Using data from Study 2, the most effective thawing temperature o f each
cryoprotectant was adopted for comparison o f the freezing rate effect on atrial and
ventricle cells. Cryopreservation conditions and evaluation criteria were the same as in
Study 2 except for the freezing rates. Atrial cells were packed into a polystyrene foam
box with four layers o f cotton (slow freezing rate), two layers o f cotton (medium freezing
rate), or no cotton (fast freezing rate). Ventricle cells were packed into a polystyrene
foam box (slow freezing rate), freezer paper box (medium freezing rate, 13 x 13 x 4.5 cm,
Sarstedt), or without packing (fast freezing rate).
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Study 4: Comparison of Optimal Conditions of Each Cryoprotectant
Based on Study 3, the optimal conditions for each cryoprotectant were determined
for cryopreservation o f atrial and ventricle cells. In addition to dehydrogenase activity
and extent of cell spreading, cell viability was evaluated using a LIVE/DEAD*
viability/cytotoxicity kit (Molecular Probes, Inc. Eugene, Oregon) according to the
manufacturer’s protocol. The number of cells recovered was counted with a
hemocytometer after detachment from the wells with trypsin (Freshney 1994). All data
were compared with data obtained from cells receiving no cryoprotectant or freezethawing steps. The percentages o f dehydrogenase activity, cell viability, and cell
recovery were calculated.

Statistical Analysis
The data for dehydrogenase activity were analyzed by two-factor analysis o f
variance in Study 1 (cryoprotectants and concentrations), Study 2 (cryoprotectants and
thawing temperatures), and Study 3 (cryoprotectants and freezing rates) and the data for
dehydrogenase activity, cell viability, and total cell number were analyzed by one-factor
ANOVA in Study 4 (cryoprotectants). Whenever a significant difference was found
(P < 0.0S), the Tukey multiple means comparison was performed.

Results
Study 1: Comparison of Cryoprotectants and Concentrations
Cryoprotectant type and concentration significantly affected dehydrogenase
activity o f atrial and ventricle cells. Significant interaction was observed between
cryoprotectant type and cryoprotectant concentration for cryopreserved atria (P = 0.0001)
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and ventricle cells (P =

0 .0 0 0

lXFigure 3 .]). Compared with non-cryopreserved atrial

cells (267 ± 20, A4 9 0 ), a 74% reduction o f dehydrogenase activity was found for atrial
cells which were cryopreserved with 10% DMSO (96 ± 6 A4 9 0 )- A 53% reduction o f
dehydrogenase activity compared to non-frozen ventricle cells (196 ± 5 A4 9 0 ) was found
for ventricle cells, which were cryopreserved with 10% glycerol (92 ± 8 A4 9 0 ).
In the evaluation o f cell spreading for each cryoprotectant treatment, atrial cells
tended to form clumps in all cryoprotectant treatments. The ranked order o f cell
spreading for each cryoprotectant treatment was 10% glycerol (++++), 10% DMSO
(+++) and 10% (++) PG. Cells that received no cryoprotectant showed the least cell
spreading (+). For ventricle cells, less clumping was found in all cryoprotectant
treatments. The ranked order o f cell spreading for each cryoprotectant treatment was
10% glycerol (+++), 10% DMSO (++) and 10% PG (++). Cells receiving no
cryoprotectant showed the least cell spreading (+). Based on the dehydrogenase activity
and extent of cell spreading, 10% o f each cryoprotectant was selected for Study 2.

Study 2: Comparison of Thawing Temperature
The thawing temperature did not significantly affect dehydrogenase activity o f
atrial cells that were treated with DMSO, glycerol or PG (Figure 3-2). No interaction
was found between cryoprotectants and thawing temperatures (P = 0.3159). Regardless
o f the cryoprotectant, dehydrogenase activity o f atrial cells thawed at 45° C (73 ± 25
A 490)

was significantly higher than that o f cells thawed at 25° C (67 ± 27 A4 9 0 ) or at 70° C

(65 ± 27 A4 9 0 ) and no significant difference was found for cells thawed at 25° C and 70°
C. Regardless o f thawing temperature, significantly different (P < 0.05) dehydrogenase
activities were found among atrial cells treated with DMSO (67 ± 9 A4 9 0 nm), glycerol
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Figure 3-1. The effect of cryoprotectant and concentration on dehydrogenase activity of
atrial and ventricle cells. Cells were frozen with dimethyl sulfoxide (DMSO), glycerol,
and propylene glycol (PG) at three concentrations and thawed at 45° C. Dehydrogenase
activities o f thawed cells were evaluated after 3 d o f culture. Bars sharing letters (A, B,
C, D, E, and F) were not significantly different (P > 0.05).
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Figure 3-2. The effect o f thawing rate on dehydrogenase activity o f atrial and ventricle
cells. Cells were frozen with a 10% final concentration o f glycerol, dimethyl sulfoxide
(DMSO), and propylene glycol (PG), and were thawed at three temperatures. The
control indicates that cells were frozen without cryoprotectant. Dehydrogenase
activities o f cells were evaluated after 3 d o f culture. Bars sharing letters (A, B, C, D, E,
and F) were not significantly different (P > 0.05).
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(99 ± 8 A4 9 0 ), and PG (40 ± 9 A4 9 0 ) A 69% decrease, compared with non-frozen atrial
cells (336 ± 3 A4 9 0 ), was found for atrial cells cryopreserved with 10% glycerol and
thawed at 45° C (103 ± 10 A4 9 0 ).
For ventricle cells, an interaction was found between thawing temperature and
cryoprotectant (P = 0.0001). The highest dehydrogenase activity (134 ± 8 A4 9 0 ), which
was 40% o f the dehydrogenase activity found in non-cryopreserved ventricle cells (333 ±
4 A4 9 0 ), was observed in ventricle cells cryopreserved with 10% glycerol and thawed at
25° C (Figure 3-2).
Thawing temperatures did not affect atrial cell spreading in each cryoprotectant
treatment but did affect ventricle cell spreading. The best ventricle cell spreading (++++)
was found in cells frozen with 10% glycerol and thawed at 25° C. Based on these results,
thawing temperatures o f 4S° C for atrial cells and 25° C for ventricle cells were selected
for Study 3.

Study 3: Comparison of Freezing Rates
There were significant interactions between cryoprotectant and freezing rate (for
atrial cells, P = 0.0001; for ventricle cells, P = 0.0001). The highest dehydrogenase
activity (92 ± 7 A4 9 0 ), which was 63% of that o f the non-cryopreserved atrial cells (146 ±
10 A4 9 0 ), was found in cells treated with 10% glycerol and frozen at the medium rate
(Figure 3-3). The same trend was seen in ventricle cells for which dehydrogenase
activity (78 ± 18 A4 9 0 ) was 44% o f that of the non-cryopreserved cells (179 ± 1 5 A4 9 0 ).
The best atrial cell spreading was found at the fast freezing rate for the DMSO
treatment (+++), and the medium freezing rate for the glycerol treatment (++++) and the
PG treatment (++). For ventricle cells, the best cell spreading was found with the
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Figure 3-3. The effect o f freezing rate on dehydrogenase activity o f atrial and ventricle
cells. Cells were frozen with 10% o f glycerol, dimethyl sulfoxide (DMSO) and
propylene glycol (PG) at three freezing rates. The control indicates that cells were
frozen without cryoprotectant. Atrial cells were thawed at 4S° C and ventricle cells were
thawed at 2S° C. Dehydrogenase activity o f cells was evaluated after 3 d o f culture.
Bars sharing letters (A, B, C, D, and E) were not significantly different (P > 0.0S).
51

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

medium freezing rate for the DMSO treatment (++), the glycerol treatment (++++) and
the PG treatment (++). Based on the highest dehydrogenase activity and cell spreading,
the following conditions were chosen for Study 4: for atrial cells, a fast freezing rate
using 10% DMSO and a medium freezing rate using 10% glycerol and 10% PG; for
ventricle cells, a medium freezing rate was selected.
Study 4: Comparison of Optimal Conditions of Each Cryoprotectant
The highest percentages o f cell dehydrogenase activity, recovery, and viability
were found in glycerol-treated atrial and ventricle cells (Figure 3-4). Regardless o f the
cryoprotectant, atrial cells tended to clump (Figure 3-Sb, c, and d). This phenomenon
was also found in control cells that received no cryoprotectant or cryopreservation
(Figure 3-5a). Fragments o f lysed cells were found in PG-treated cells (Figure 3-5d).
The best spreading atrial cells were found with glycerol (++++) followed by DMSO
(+++) and PG (++). Clumps were also formed in ventricle cells and control cells that
received no cryoprotectant or cryopreservation (Figure 3-6). Fragments o f lysed cells
were found in DMSO-treated and PEG-treated ventricle cells (Figure 3-6b and 3-6d).
The best cell spreading o f ventricle cells was found in glycerol-treated cells
(++-H-)(Figure 3-6c).

Discussion
In vitro studies o f vertebrates have greatly enhanced the availability o f
cryopreserved cells. For oysters, in vitro studies are hampered due to the lack o f
cryopreservation protocols for cells and cell lines. In the present study, the first effective
conditions for cryopreservation o f atrial and ventricle cells o f oysters were developed.
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Figure 3-4. Comparison o f the percentages o f ceil dehydrogenase activity, cell recovery
rate and viability o f atria and ventricle cells after thawing. The control indicates that
cells were frozen without cryoprotectant (glycerol, dimethyl sulfoxide, DMSO, and
propylene glycol, PG). These percentages were compared to those o f untreated cells
that received no cryoprotectant and cryopreservation. Cells were thawed at the optimal
condition as follows: for atrial cells with 10% cryoprotectant, freezing at a medium rate
and thawing at 45° C; for ventricle cells with 10% cryoprotectant, freezing at a medium
rate and thawing at 25° C. Bars sharing letters (A, B, C, and D) were not significantly
different (P > 0.05).
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Figure 3-5. The spreading o f thawed atrial cells after 3 d o f culture. Cells were thawed
at optimal conditions (10% cryoprotectant, freezing at a medium rate and thawing at 45°
C). (a) Untreated cells which received no cryoprotectant and no cryopreservation; (b)
cells treated with 10% dimethyl sulfoxide; (c) cells treated with 10% glycerol, and (d)
cells treated with 10% propylene glycol. Bar = 20 pm.
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Figure 3-6. The spreading o f thawed ventricle cells after 3 d o f culture. Cells were
thawed at optimal conditions (10% cryoprotectant, freezing at a medium rate and thawing
at 25° C). (a) Untreated cells which received no cryoprotectant and no cryopreservation;
(b) cells treated with 10% dimethyl sulfoxide; (c) cells treated with 10% glycerol, and (d)
cells treated with 10% propylene glycol. Bar = 20 pm.
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Osmotic shock and physical injury from ice crystals are two major factors causing
cell death during freezing and thawing (Leung 1991). Addition o f cryoprotectants, and
optimization o f freezing and thawing rates can minimize the damage to cells. Based on
this study, cryopreservation o f a cell line will be possible once it is established.
Meanwhile, a frozen source o f primary oyster cells will help to avoid problems with
seasonal contamination.
Dimethyl sulfoxide is more toxic to animal cells than is glycerol but it can
penetrate cell membranes faster due to its smaller molecular weight (Leung 1991). At a
specific concentration, decreasing the exposure time or increasing the freezing rate can
minimize the toxicity o f DMSO to cells. In this study, atrial cells treated with 10%
DMSO and frozen at a fast rate showed a higher dehydrogenase activity than that o f cells
frozen at medium and slow rates. In cryopreserving animal cells, glycerol has not been
used as often as DMSO (Freshney 1994) because glycerol is viscous and difficult to
remove after thawing. Glycerol-treated oyster cells consistently showed better results in
all preliminary studies (data not shown) as well as in the four studies described here in
terms o f dehydrogenase activity, cell spreading, cell viability and number of cells
recovered. The results demonstrated that glycerol-treated oyster heart cells tolerated a
wider range of freezing and thawing rates than did DMSO-treated and PG-treated cells.
These results suggest that glycerol is a useful cryoprotectant for oyster heart cells.
Although the PG was found to be an effective cryoprotectant for embryos o f C.
gigas (Gwo 1995) and trochophore larvae of C. virginica (Paniagua-Chavez et al. 1998),
neither PG-treated atrial nor ventricle cells showed better dehydrogenase activity and cell
spreading than did DMSO-treated or glycerol-treated cells. These results suggest that the
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effective cryoprotectant for sperm, embryos and larvae may not be the same as for
dissociated somatic cells o f embryos.
During thawing, small ice crystals, which form during freezing, can grow and
cause physical injury to cells (Forsyth and MacFartane 1986). Control o f thawing
temperature can reduce damage due to ice crystals and increase cell viability. For
ventricle cells, a 25° C thawing temperature enhanced dehydrogenase activity in glyceroltreated cells. However, thawing temperature was not critical for atrial cells regardless of
cryoprotectant. This implies that a 37° C thawing temperature, used for mammalian cells,
could be used for thawing atrial cells.
Further improvement of cryopreservation conditions may be achieved by inducing
endogenous stress proteins such as heat shock proteins. Most heat shock proteins
function as chaperones, which assist protein folding and conformation stability during
stress (Morimoto 1993). For example, the viability o f human fibroblasts was increased
from 4% to 43% by heat shock treatment before hypothermic storage (Russotti et al.
1996). Heat shock proteins have been identified in C. gigas (Clegg et al. 1998).
Inducing these endogenous stress proteins before freezing may enhance the tolerance of
oyster cells, embryos and larvae.
In conclusion, the first effective cryopreservation conditions for oyster heart cells
were developed as follows: for atrial cells, use o f 10% glycerol, freezing at a medium
rate, and thawing at 45° C; for ventricle cells, use o f 10% glycerol, freezing at a medium
rate, and thawing at 25° C. These conditions will improve oyster in vitro studies due to
the availability and uniformity of cryopreserved oyster cells. Meanwhile they provide
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basic information for further development o f cryopreservation conditions for oyster cell
lines when they are established.
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CHAPTER 4 IN VITRO EVALUATION OF INDUCIBLE HETEROLOGOUS
PROMOTER FUNCTION IN THE EASTERN OYSTER
Introduction
Oyster culture has been plagued by diseases worldwide (Di Salvo et al. 1978,
Hine et al. 1992, and Doonan et al. 1994). H aplosporidivm nelsoni, the causative agent
o f MSX disease, and Perkinsus m arinus, the causative agent o f Dermo disease in eastern
oysters, has led to a dramatic decrease in landing weight along the East coast (Andrews
1988, Haskin and Andrews 1988) and in the Gulf o f Mexico o f the United States
(Andrew and Ray 1988).
Eradication o f pathogens, drug treatments, vaccination, and breeding for genetic
improvement are strategies usually used to control infectious diseases in animals,
however, most o f these approaches are not practical in oysters. Eradication o f pathogens
in oysters is difficult because they inhabit open bays and estuaries. Use o f
chemotheraputants is only feasible for broodstock and larvae in hatcheries, and the
concern o f inducing antibiotic-resistant pathogens limits the practice (Elston 1984, Calvo
and Burreson 1994, Faisal et al. 1999). Moreover, vaccination cannot be used due to the
lack o f an acquired immunity in oysters (Ratdiffe et al. 198S). Therefore, produdng
disease resistant strains by genetic improvement may be a feasible strategy to control
oyster infectious diseases.
Unfortunately, results o f conventional genetic techniques, such as chromosome
manipulation and selective breeding are disappointing because disease resistance related
genes are difficult to enhance or select specifically. For example, by chromosome
manipulation, triploid oysters were generated and found to be as susceptible to Dermo as
diploid oysters (Barber and Mann 1991). By selective breeding o f spontaneously
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occurring genetic resistant strains to MSX, a resistant strain was developed (Ford and
Haskin 1987), but undesirable genetic traits were found such as slow growth and lack o f
resistance to Dermo (Burreson 1991). Currently, the development o f gene transfer
techniques allows disease-resistant genes such as antimicrobial peptides to be specifically
introduced into oysters to enhance disease resistance.
Because gene expression is mainly controlled by the promoter, selection o f a
promoter to control gene expression is a critical step for studying disease resistance in
oysters. Promoters originating from the same species (homologous promoters) allow
better control o f gene expression than those from different species (heterologous
promotersXDu et al. 1992, Takagi et al. 1994, Devlin et al. 1994). When homologous
promoters are not available, heterologous promoters can be adapted, based on the
phylogenetic conservation o f gene regulation.
Promoters can be categorized into one o f the two categories: constitutive o r
inducible promoters. Constitutive promoters constantly drive gene expression and are
used to express genes continuously. Inducible promoters respond to specific inducers to
drive gene expression and can be used to regulate transgene expression. Specific inducers
can be: 1) physical factors such as radiation (Datta et al. 1992, Hallahan et al. 1995), heat
shock (Lis et al. 1983, Bienz and Pelham 1982, Zhang et al. 1998), and light (Peng et al.
1998); 2) chemical factors such as ethanol (Umeno et al. 1988), hormones (White 1997),
or metals (Murphy et al. 1990, Inoue et al. 1992, Kinoshita et al. 1994); or 3) biological
factors such as viruses (Hug et al. 1988, Chang et al. 1991).
Inducible promoters are the best candidates for controlling the expression o f
disease-resistance (effector molecule) genes. Inducible gene expression patterns can
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prevent host tissues from being damaged by over-expression o f effector molecules
(Babior 1984). For oysters, because no homologous inducible promoter has been cloned,
the adaptation o f an inducible promoter from a phylogenetically related species becomes
necessary. Thus, the promoter o f the snail, Biom phalaria giabrata, heat shock protein 70
(HSP 70) gene and the promoter of the moth, H yalophora cecropia, cecropin B gene
were chosen for evaluation.
The regulation o f heat shock response genes, including the heat shock DNA
sequence in the promoter and heat shock transcription factors of the host, are conserved
among species (Holmgren et al. 1981, Pelham 1982, Corces et al. 1981, Scharf et al.,
1990). For example, the heat shock 70 promoter from D rosophila was shown to function
in a heat inducible manner in cell lines derived from a broad spectrum o f animal
classifications, such as sea urchin (echinodermXMcMahon et al. 1984), oyster (mollusc)
(Boulo et al. 1996), mosquito (insectXZhao and Eggleston 1999, Shotkoski et al. 1996,
Miller et al. 1987), frog (amphibian)(Voellmy and Rungger 1982), trout (fish)(Inoue et al.
1990), and mammalian cells (Roigas et al. 1997).
In addition, heat shock response genes can be induced by physiological stresses
including trauma, inflammation, infection, and cancer (Morimoto and Santoro 1998),
chemical stress such as ethanol (Hahn et al. 1985), and physical stress such as placement
in a magnetic field (Goodman and Blank 1998). Therefore, heat shock promoters have
the potential to drive expression o f effector molecule genes in response to stressors. For
this reason, we looked first at the promoter from snail (Biom phalaria giabrata) heat
shock 70 gene (SHSP-70)(Yoshino et al. 1998).
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The cecropin B promoter, which functions in a similar way to promoters of
mammalian acute phase response (APR) genes, can be induced by pathogen invasion
early in the infection and shut down after the pathogens have been eliminated (Boman et
al. 1991, Baumann and Gauldie 1994). The APR genes and their regulatory components,
including cell receptors, signal transduction pathways, transcription factors and promoter
sequences (Hultmark 1993), are conserved. For example, the binding site for nucleus
factor kappa-B (NF-kB), which regulates most APR genes, is present in the cecropin B
promoter and all other lytic peptide promoters that have been cloned to date (Barra et al.
1998).
Although the cytokines that mediate APR have not been identified in oysters,
cytokine-like molecules o f interlukin (IL)-1, IL-6, tumor necrosis factor-alpha, which
mediate the regulation of APR genes in mammals (Heinrich et al. 1990, Baumann and
Gauldie 1990, Castell et al. 1989) and their receptors were found in blue mussels, M ytilus
edulis, (Hughes et al. 1990, 1991, 1992, Ottaviani et al. 1993, 1997). The presence o f
cytokine-like molecules and their receptors in a bivalve suggests that they might exist in
oysters to mediate the signal for the cecropin promoter. Thus, the cecropin B (APR)
promoter was chosen for evaluation.
To conduct in vitro gene function studies, a well-established cell culture and gene
expression system is needed but this is not available for oysters. Thus, the optimized cell
culture conditions from our previous studies were used to establish gene transfer and
expression systems.
The objectives were: 1) optimization o f transfection conditions for oyster cells, 2)
evaluation o f SHSP-70 promoter, and 3) evaluation o f APR promoter.
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Materials and Methods
Plasmids
Plasmid (pPC) containing the SHSP-70 promoter with a luciferase reporter gene,
was provided by Dr. Yoshino (Department of Pathobiological Sciences, University o f
Wisconsin at Madison). The snail heat shock promoter w as deleted to generate plasmid
(pNPC) as a negative control for the transfection assay. Plasmid (pAPR/GL3E)
containing the APR promoter was constructed by PCR amplification o f the cecropin B
promoter from the cecropin B gene followed by cloning into the multiple cloning site o f
pGL3E in frame with the luciferase gene (Appendix F).
Cell Culture
Oyster ventricle cells were dissociated using pronase as described in Chapter 2.
The dissociated cells were resuspended in LA-3 medium (Appendix D) and cultured in
96 well-plates at a density o f 4 x 105 cell/100 pi/well at 25° C for 3 d to allow cell
attachment and spreading.
Cell Transfection and Heat Shock
Transfection was performed using an Effectene transfecting kit (Qiagen Inc.
Valencia, California) containing EC buffer for DNA dilution, Enhancer for condensing
DNA and Effectene for the formation o f lipid-DNA complex to deliver DNA into cells.
For the DNA to be condensed by the Enhancer, the concentration o f DNA specified for
each study was diluted to 30 pi using EC buffer followed by the addition o f Enhancer at
ratio o f 1:8 (pg DNA:pi Enhancer) and incubation at room temperature for 5 min.
Second, for the formation o f Effectene-Enhancer-DNA complexes, Effectene was diluted
to 20 pi using EC buffer and added to the condensed DNA. Then, the Effectene-
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Enhancer-DNA complexes were added to wells containing cells after incubation at room
temperature for 10 min. Based on preliminary studies, cells were incubated with
Effectene-Enhancer-DNA complexes at 25° C for 16 h and were heat shocked at 40° C
for 1 h followed by recovery at 2S° C for 12 h before the luciferase assay.

Luciferase Assay
Cell extract preparation: Luciferase activity o f cells was measured using a
Luciferase assay system (Promega Corporation, Madison, Wisconsin). The medium was
removed and the cells were washed once using 100 pi o f sterile artificial seawater
(FASW) (Instant Ocean, Aquarium Systems Inc., Mentor, Ohio). Fifty pi o f cell culture
lysis reagent (25 mM Tris-phosphate pH 7.8; 2 mM DTT; 2 mM 1,2-diaminocyclohexane
-N,N,N’,N’-tetraacetic acids; 10% glycerol; 1% Triton® X-100) were added to lyse cells.
Cells attached to the bottom o f wells were removed by pipetting the cell culture lysis
reagent into the wells. Cell lysates were transferred to a 0.2 ml tube, incubated 5 min at
room temperature, and centrifuged at 12,000 x g for 5 sec. Supernatants were transferred
to a new micro tube and stored at - 80°C until luciferase activity could be measured.

Measurement of luciferase activity: Cell extracts and the assay reagents were
thawed in a 25° C w ater bath. Assays were conducted at room temperature (25° C).
Twenty pi o f cell extract were added to a 1.8-ml glass vial (Fisher Scientific, Pittsburgh,
Pennsylvania) and placed in the chamber of a luminometer (Model 20e, Turner Designs,
Sunnyvale, California). Then, 100 pi of luciferase assay reagent containing luciferase
substrates were injected into the vial. Light production was measured for 10 sec. The
results were recorded as relative light units (RLU).
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Study 1: Optimization of DNA to Effectene Ratio
Cells receiving no Effectene or DNA and cells receiving Effectene only were used
as negative controls. Three pPC DNA concentrations (0.1, 0.2, and 0.3 pg) at three ratios
(1:10, 1:25 and 1:50) o f DNA to Effectene were evaluated. The optimal ratio o f DNA to
Effectene was chosen for the following studies.

Study 2: Optimization of DNA Concentration
Cells were transfected with 0.2, 0.3 and 0.4 pg o f pPC DNA at a ratio o f 1:10 of
DNA to Effectene for optimization o f DNA concentration. Cells receiving Effectene only
(0 pg DNA) were used as a negative control. The optimal concentration was chosen for
the following studies.

Study 3: Heat induction of SHSP-70 Promoter
Cells were transfected with 0.3 pg o f pNPC or pPC DNA to determine whether
heat induction o f luciferase activity could be mediated by the SHSP-70 promoter. Cells
without Effectene and cells with Effectene only were used as negative controls. To
decrease the variation per treatment, 12 replicate wells o f each cell treatment were
prepared. Each o f 12 wells was lysed with 20 pi o f cell culture lysis buffer and every 4
wells were pooled which resulted in each treatment containing 3 replicate pools. The
following studies were all conducted as described above.

Study 4: Time course response of SHSP-70 Promoter
Cells were transfected with 0.3 pg pPC DNA to determine a time course response.
Luciferase activity was measured at 0, 3, 6, 9,12, and 24 h after heat shock. The time
yielding the highest expression was chosen for the following studies.
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Study 5: Temperature Course Response of Snail Heat Hhoclc 70 Promoter
Cells were transfected with 0.3 pg pPC DNA to evaluate the temperature yielding
the best luciferase activity. Transfected cells were heat shocked at 30, 35, 40, or 45° C
for 1 h. Luciferase activities were measured 12 h after heat shock. The optimal heat
shock temperature was chosen for the following study.

Study 6: Evaluation of the APR Promoter
Cells transfected with pPC were heat shocked to serve as a positive control of
transfection. Cells transfected with pPC but not shocked, were used to provide a negative
control for activation o f the promotor. All transfections in this study used a ratio o f 1:10
(DNA to Effectene) and 0.3 pg DNA. Cells transfected with pGL3E were used as a
negative (no APR promoter) control while cells transfected with pAPR/GL3E were used
for the evaluation o f induction o f the APR promoter sequence. Ten pg/ml/well of LPS
which is prepared form Salm onella enteritidis using phenolic extraction and gel filtration
chromatography (Sigma, product number L 7770) and/or 20 pg/ml/well o f recombinant
mouse IL -1-alpha (Sigma, product number I 5396) were added to induce the APR
promoter 16 h after transfection. Luciferase activity was measured at 6 h and 12 h after
the addition o f LPS and IL-1.

Data Analysis
Each treatment in each Study contained 3 replicates. Studies I to 5 were repeated
twice and Study 6 was conducted once. Data from each study were analyzed using
analysis o f variance (ANOVA). Duncan’s multiple range test was performed when
significant differences were found (P < 0.05).
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Results
Study 1: Optimization of DNA to Effectene Ratio
Significant differences in luciferase activity were found among cells transfected at
a ratio o f 1:10 o f DNA to Effectene compared to those o f 1:25 and 1:50. Cells
transfected with 0.3 pg DNA showed the highest (0.069 ± 0.020) (P < 0.05) luciferase
activity, and were significantly different compared to the cells o f DNA-only control
(0.006 ± 0.020) and Effectene only control (0.007 ± 0.025) (Figure 4-1). Cells
transfected at ratio o f 1:25 and 1:50 showed no significant difference compared to control
cells and cells transfected with DNA. Therefore, a ratio o f 1:10 was chosen for further
studies.

Study 2: Optimization of DNA Concentration
Cells transfected with 0.2, 0.3 pg DNA showed a significant difference in
luciferase activity compared to cells receiving Effectene only (0.010 ± 0.015) (Figure 42). Cells transfected with 0.3 pg DNA showed the least variation and the highest
luciferase activity (0.108 ± 0.062) compared to other treatments. Thus, 0.3 pg o f DNA
was chosen for further studies.
Study 3: Heat Induction of SHSP-70 Promoter
Heat induction o f luciferase activity was seen only in cells containing the SHSP70 promoter. Cells transfected with pNPC showed no significant increase in luciferase
activity with or without heat shock (Figure 4-3). A ten-fold increase in luciferase activity
was found after heat shock, between cells transfected with pPC and cells transfected with
pNPC.
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Figure 4-1. Optimizing the o f DNA to Effectene ratio. Cells were transfected with
Effectene at the indicated DNA concentration and DNA to Effectene ratio. After
transfection, cells were heat shocked at 40° C for 1 h, and recovered at 25° C for 12 h and
used in a luciferase assay. Bars without letters indicate no significant difference in
luciferase activity compared to controls and Effectene only cells. Bars sharing letters (A,
B, and C) were not significantly different (n = 6, P > 0.05).
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Figure 4-2. Optimization of DNA concentration. Cells were transfected with the
indicated DNA concentration. Luciferase activity was measured 12 h after heat shock at
40° C for 1 h. Bars sharing letters (A and B) were not significantly different (n = 6, P >
0.05).
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Figure 4-3. Heat induction of the heat shock protein 70 promoter from snail (SHSP-70).
Cells were transfected with pNPC containing no snail heat shock promoter and pPC
containing the SHSP-70 promoter. Bars sharing letters (A and B) were not significantly
different (n = 6, P > 0.05).
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Study 4: Time Course Response of SHSP-70 Promoter
A significantly higher luciferase activity (0.114 ± 0.033) was detected at 12 h, as
opposed to the other time points (Figure 4-4). A significant increase in luciferase activity
was not detected until 6 h (0.0S1 ± 0.014) while a significant decrease o f luciferase
activity was found at 24 h (0.080 ± 0.018)(Figure 4-4). Therefore, 12 h was chosen for
the following studies.

Study S: Temperature Effect on Inducing the SHSP-70 Promoter
The optimal heat shock temperature was 40 °C. Cells receiving no DNA, and
cells transfected with 0.3 pg pPC DNA showed no significant difference in luciferase
activity after heat shock at 30° C (0.001 ± 0.007 vs. 0.006 ± 0.010). A significantly
higher luciferase activity was found at 40° C (0.102 ± 0.030) followed by 45° C (0.084 ±
0.011) and 35° C (0.050 ± 0.027)(Figure 4-5).

Study 6: Evaluation of APR Promoter
The induction o f the APR promoter was not significantly different from the
controls at 6 h and 12 h after the addition o f LPS and IL-1. The heat-shock control cells
transfected with pPC showed a significantly higher luciferase activity compared to those
without heat shock (Figure 4-6). The pAPR/GL3E transfected cells showed higher
luciferase activities than those o f pGL3E transfected cells at 6 h and 12 h after the
addition o f IL-1 (Figure 4-6) but the difference was not significant (P > 0.05).

Discussion
A system for gene transfer and expression is essential for in vitro studies. In vitro
gene transfer is well established for vertebrate cells but in vitro gene transfer for
invertebrates is limited to a few species such as D rosophila, mosquito, and snail
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Figure 4-4. Activation time course o f the snail heat shock protein 70 promoter gene.
Cells were transfected with pPC DNA and heat shocked at 40° C for 1 h followed by a
luciferase assay at the indicated time. * indicates a significant difference in luciferase
activity was found between cells transfected with 0 pg DNA and 0.3 pg DNA. Points o f
cells transfected with 0.3 pg DNA sharing letters (A, B, C, and D) were not significantly
different (n = 6, P > 0.05).
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(Marshall 1998, Lardans et al. 1996). No cell line is available and the lack o f established
primary cell culture conditions hinder the development o f a gene expression system for
marine bivalves. In this study, we developed the first reported serum-free gene
expression system used for evaluating promoters.
A primary heart cell culture from the pacific oyster (C. gigas) is the only marine
bivalve somatic cell type, which has been transfected (Boulo et al. 1996). However, the
cells were transfected with a lipid-based transfection reagent N-[l-(2,3-dioleoyloxy)N,N,N-trimethylammonium methylsufate] (DOTAPXRoche, Mannheim, Germany) and
the cells were cultured in 2X L-15 medium containing 10% fetal bovine serum (FBS).
The DOTAP was one o f the first lipid-based transfection reagents and at least 5 to 10
times amount o f DNA was required to transfect cells compared to more recent
transfection reagents. Although DOTAP is often used to mediate gene delivery for insect
cells (Lardans et al. 1996, Zhao and Eggleston 1999), it is not a universal transfection
reagent that can transfect every cell type. To identify a more efficient transfection
reagent, preliminary studies o f comparing DOTAP, Lipofectamine (Life Technologies,
Gaithersburg, Maryland), and Effectene were conducted. Ventricle cells could not be
transfected with either DOTAP or Lipofectamine, while ventricle cells could be
transfected by Effectene. In addition, the use o f Effectene required 10 times less DNA
than those o f using a DOTAP transfection reagent.
Using L-1S medium, which is designed for mammalian cell culture, is not optimal
for oyster cell primary cultures. Meanwhile, the addition o f FBS containing unknown
components (Freshney 1994), increases the complexity and decreases the usefulness o f in
vitro assays. Purification o f recombinant antimicrobial peptides (Choi 1996) and studies
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o f P. m arinus proteases (La Peyre et al. unpublished data) were hindered by the presence
o f serum in culture medium. In this study, LA-3 medium was used. This is a serum free,
chemically defined media that has been optimized for oyster cells (La Peyre et al.
unpublished data). Results o f this study indicated that LA-3 medium could support
ventricle cells to allow gene expression studies.
The study o f heat shock protein o f oyster hemocytes indicated that an increase in
heat shock proteins was found as early as 1 h after heat shock at 41° C (Tirard et al.
1995), but in this study, a significant increase o f luciferase activity was not found 3 h
after heat shock at 40° C. Whether the heat shock temperature affect the time needed for
the detection o f significant increase o f luciferase remains to be studied.
While promoter sequences o f heat shock genes are conserved among different
species, the temperature required to induce the heat shock promoter is dependent on the
physiological temperature o f the individual host species (Lindquist 1986, Abravaya et al.
1991). Induction o f D rosophila heat shock 70 promoter is found with a temperature shift
from 25° C to above 28° C in Drosophila. However, in human H9T cells, the D rosophila
HSP 70 promoter does not respond to 37° C which is the normal culture temperature of
H9T cells, but does respond to a shift from 37° C to 42° C, which activates human heat
shock promoters (Schweinfest et al. 1988). These results indicate that the activation o f
heterologous heat shock promoters is determined by host transcription factors which can
be activated by heat stress or other stresses such as chemical stress, i.e. cadmium chloride
(Liu et al. 1994).
In the study o f heat shock proteins o f oyster hemocytes, the heat shock proteins
were induced by a shift from 20° C to above 40° C (Tirard et al. 1995) and a shift from
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12° C to 37° C (Clegg et al. 1998.), suggesting that heat shock transcription factors are
activated at 37° C and above. In this study, a shift from 25° C (cell culture temperature)
to 35° C and above could induce the SHSP-70 promoter, implying that heat shock
transcription factors recognize the SHSP-70 promoter and are activated at 35° C.
Induction of the SHSP 70 promoter was not seen in the serum-free oyster cell
cultures o f this study, either at normal culture temperatures (25° C) or after heat shock
(30° C). The induction o f the D rosophila HSP 70 promoter was found at 18° C constant
culture temperature (Boulo et al. 1996), without heat shock treatment. The stresses o f
cell culture conditions, such as the presence o f serum, which can increase the basal
transcription o f HSP 70 genes (Wu et al. 198S) or the transfection process itself, could be
causing this induction.
The results of our study suggest that the heat induction o f SHSP-70 promoter is
tightly regulated by the intensity o f heat applied. This heat inducible serum-free gene
expression system will benefit oyster in vitro studies, such as that o f lytic peptide gene
function or the function o f other genes providing disease resistance.
Activation of a cecropin gene by LPS is an immediate response in hemocytes of
channel catfish and Drosophila, and in D rosophila embryonic cells. In D rosophila cell
lines, the time required for activation o f a cecropin gene after the addition o f LPS (0.1
ng/ml to 100 pg/ml) was 2 h for a malignant blood neoplasm-2 (mbn-2) cell line
(Samakovlis et al. 1992) and 4 h for an embryonic SL2 cell line (Samakovlis et al. 1990).
The number o f mbn-2 cells responding to LPS by cecropin expression was 10 fold higher
than that o f SL2. For channel catfish leukocytes transfected with a cecropin B promoter
linked to a gene for green fluorescent protein (GFP), the induction o f a two-fold increase
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o f GFP mRNA was detected 10 h after addition o f 125 pg/ml LPS (Zhang et al. 1998).
Although primary ventricle cells cultured in this study contained at least 30 to 40%
hemocytes, the induction o f the cecropin B promoter in our studies was not seen at 6 h
and 12 h after the addition o f LPS.
The absence o f serum may be a valid explanation for the lack o f cecropin B
promotor induction. All the media used for lytic peptide gene expression assays in
insects, fish or other animals, contain serum. The addition o f serum is mainly for cell
growth support but the components of serum may be required as cofactors to stimulate
hemocyte cytokine production thereby inducing the APR promoter. One o f the key
serum factors necessary for macrophages to recognize LPS is LPS-binding protein
(Mathison et al. 1992). In mammals, the NF-kB transcription factor, a major coordinator
o f innate immunity genes (Siebenlist et al. 1994), is activated by LPS or pathogen
challenge to bind the promoter NF-kB sequence and facilitate the activation o f innate
immunity genes. In insects, similar transcription factors are involved in the same role in
the activation o f lytic peptide genes (Ip et al. 1993, and Petersen et al. 1995). Whether
LPS binding protein is required for activation o f the transcription factors in mammals or
insects is unknown. However, LPS-binding protein can increase the production o f
cytokines such as tumor necrosis factor (TNF) in LPS-treated macrophages (Mathison et
al. 1992) and the production o f those cytokines can enhance the expression o f effector
molecule genes. It remains to be studied whether LPS binding protein or other serum
factors are required for ventricle cells to produce cytokines or activate the cecropin
promoter.
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The most probable cause o f the unresponsive APR promoter after the addition of
IL-1 is the dose and specificity o f IL-1. The dose of exogenous IL-1 might be not high
enough to activate APR promoters. In the snail hemocyte phagocytosis assay, 500 ng/ml
IL-1-alpha, which is 25-fold more than the IL-1-alpha concentration in this study, was
used to enhance phagocytosis activity (Ottaviani and Franchini 1995). Meanwhile,
cytokines may show species specificity for mollusc hemocytes. In the hemocyte
migration assay o f two fresh water snails, TNF-alpha (1 U/ml) enhanced the migration of
hemocytes o f Planorbarius com eus but not those o f Viviparus ater (Ottaviani and
Franchini 1995).
The lack o f serum factors, and the low dose and specificity o f IL-1 might explain
why the APR promoter was not activated when both LPS and IL-1 were added. Further
studies need to be conducted to verify the above possible explanations individually.
In conclusion, an in vitro gene transfer, heat inducible, serum-free gene
expression system was established. By using this system, we found that the SHSP-70
promoter was activated in response to heat shock but the promoter (APR) o f the cecropin
B gene was not activated after the addition o f IL-1 and LPS. Further in vitro and in vivo
studies are needed to evaluate APR promoter function. The establishment o f a
transfection system o f ventricle cells, which are cultured in serum-free medium can be
used to study gene regulation and function without the interference o f serum.
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CHAPTER 5 EVALUATION OF THE EFFECTS OF ANTIMICROBIAL
PEPTIDE GENE TRANSFER ON THE IMMUNITY OF
THE EASTERN OYSTER
Introduction
The value o f oyster production exceeded 100 million dollars in United States in
1995 (MacKenzie 1996). However, in addition to overharvesting and water quality
deterioration, diseases o f oysters and contamination with human pathogens are two major
factors hampering further development of the oyster industry. Diseases that affect
oysters have caused a decrease in oyster harvests. Pathogens causing oyster diseases
include viruses (Farley et al. 1972, 1976), bacteria (Tubiash et al. 1973, Elston et al.
1982, Dungan et al. 1989) and protozoa (Andrews 1967). The protozoan Perkinsus
m arinus is recognized as a major pathogen responsible for a decrease in production o f the
eastern oyster in the Gulf o f Mexico (Andrews and Ray 1988).
Human pathogen contamination of oysters has resulted in decreased consumer
acceptance and a decrease in the market price (Hargis and Haven 1988). Oysters are
cultured along the coast and estuarine areas where algae and bacteria are abundant. They
filter surrounding water at a rate o f up to 34 liters per hour to obtain algae as food
(Galtsoff 1964). Unfortunately, bacteria also accumulate in oysters during feeding. The
accumulated bacteria include human pathogens such as Vibrio vulnificus, which is nonpathogenic to adult oysters but can cause gastroenteritis and septicemia in humans.
Between 1988 and 1996, a total o f 422 cases of V vulnificus infection were reported
(Shapiro et al. 1998). Forty-one percent of the patients had consumed raw oysters.
Sixty- one percent o f the patients who consumed raw oysters died as a result o f the
infection (Shapiro et al. 1998). Therefore, contamination with human pathogens becomes
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a major concern in summer months, when the pathogens are most abundant (Wright et al.
1996). To alleviate contamination problems, radiation and depuration (culturing oysters
in clean water) have been suggested to reduce bacteria loading in oysters. However,
radiation did not receive Food and Drug administration (FDA) approval, and depuration
was not efficient in eliminating or reducing human pathogens such as V. vulnificus
(Tamplin and Capers 1992, Jones et al. 1991). Although, adding food preservatives such
as 0.05% diacetyl (2,3-butadione) can also eliminate V vulnificus, the cost and lack o f
consumer acceptance have limited the application o f this practice (Sun and Oliver 1994).
Vaccine immunization is not possible for oysters, since they lack amnesis and
cannot mount a response based on pathogen recognition. Because o f this fact, the word
“immunity” must be understood in a very broad sense when applied to oysters, as it is
here. One feasible way to solve disease and contamination problems is to enhance non
specific oyster immunity. Oysters rely on innate immunity including cellular immunity
such as phagocytosis o f hemocytes, and humoral factors such as lectins, agglutinins,
protease inhibitors, lysozymes and antimicrobial peptides (Ford and Tripp 1996).
Improvement in the production o f these endogenous molecules or the addition o f a
functional immunity factor (effector molecule) such as an antimicrobial peptide gene to
the oyster genome may increase disease resistance and reduce accumulation o f human
pathogens.
Antimicrobial peptides were first isolated from insects (Boman et al. 1972).
Thereafter, antimicrobial peptides have been found in plants (Broekaert et al. 1997), and
animals (Boman 1995) as non-specific immune effector molecules. These antimicrobial
peptides typically consist o f 23 to 39 amino acids, and can be either stored
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(compartmentalized) in cells such as macrophages for intracellular killing, or secreted for
extracellular killing o f pathogens (Boman 1995). In addition to antibacterial, antifungal,
and antiparasitic activities (Boman 1991, 1995), these antimicrobial peptides confer
diverse functions, such as binding to bacterial endotoxin (Sawyer et al. 1988), promoting
wound healing (Murphy et al. 1993), stimulating monocyte migration (chemotaxis) to
targeted pathogens (Territo et al. 1989), regulating cell response to cytokines (MattsbyBaltzer et al. 1996), and enhancing the growth of mouse fibroblasts (Reed et al. 1992).
Antimicrobial peptides are found in many species that are important to
aquaculture such as loach, M isgum us angui/Jacaudatus (Park et al. 1997), catfish,
P arasilurus asotus (Park et al. 1998), flounder, Pleuronectes am ericanus (Cole et al.
1997), horseshoe crab, Tachypleus tridentatus (Nakamura et al. 1988), blue crab,
C allinectes sapidus (Khoo et al. 1999), shrimp, Panaeus vannam ei (Destoumieux et al.
1997), sea hare, A plysia kurodai (Takamatsu et al. 1995), mussels, M ytilus edulis
(Charlet et al. 1996), and oysters, O strea edulis and C rassostrea gig a s (Hubert et al.
1996). In vitro research has been conducted to evaluate antimicrobial activity on oyster
and human pathogens. For example, the parasitic oyster protozoa, Bonam ia ostreae and
P. m arinus, and various species o f Vibrio bacteria were effectively killed by tachyplesin
1 isolated from the hemocytes o f the Japanese horseshoe crab Tachypleus tridentatus
(Morvan et al. 1997). Furthermore, an analog o f polyphemusin, an antimicrobial peptide
derived from the hemocytes o f the North American horseshoe crab Lim ulus polyphemus,
effectively inhibited the growth o f P. m arinus, and human pathogens (Pierce et al. 1997).
Although the source and the amino acid sequences o f antimicrobial peptides vary,
the net positive charge (cationic) and amphipathic alpha helix or beta sheet structure that
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contains mostly hydrophobic amino acids on one side and hydrophilic amino acids on the
other, are characteristics common to most antimicrobial peptides (Segrest et al. 1990,
Saberwal et al. 1994, Maloy and Kari 199S, Boman 1995). The positive charge and
amphipathic structures of antimicrobial peptides are correlated with their antimicrobial
activities (Lee et al. 1986, Oh et al. 1999). In keeping with this basic structure,
antimicrobial peptide analogs (Maloy and Kari 1995, Saido-Sakanaka et al. 1999), newly
designed antimicrobial peptides (Blondelle and Houghten 1992, Bessalle et al. 1993,
Javadpour et al. 1996, Oren et al. 1997, Tossi et al. 1997) and hybrid peptides (Shin et al.
1998, 1999) were developed. Antimicrobial peptides are promising candidates for
enhancing oyster innate immunity due to their broad-spectrum antimicrobial activities,
multiple functions, and availability o f various analogs.
The antimicrobial peptide cecropin B has been studied extensively. Cecropin B
was isolated from the giant silk moth Hyalophra cecropia (Hultmark et al. 1980) and
possesses antimicrobial (Hultmark et al. 1982) and anticancer activities (Moore 1994).
Channel catfish, Ictalurus punctatus showed enhanced resistance to the bacterial
pathogen Edwardsiella ictaluri after in vivo administration o f cecropin B and analog
peptides (Kelly et al. 1993). Moreover, transfer o f the cecropin B gene to channel catfish
reduced bacteria loading and mortality after challenge with E. ictaluri (Cooper et al.
unpublished data). Because o f promising preliminary results and availability, the gene o f
cecropin B peptide was chosen for in vivo oyster studies. In addition, the gene o f a newly
designed 24 amino acid peptide (LOKI-24) with amphipathic structure was chosen for
evaluation.
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Gene transcription can be detected at the RNA level by Northern blot (Alwine et
al. 1977) and RNase protection assay (Belin 1996). However, reverse transcriptasepoly merase chain reaction (RT-PCRXKawasaki 1990) has increasingly been used as an
alternative due to better sensitivity. The first step in the procedure is to isolate RNA from
experimental cells and transcribe it back into single strand complementary DNA
(sscDNA) using a reverse transcriptase. The sscDNA can be used in a polymerase chain
reaction (PCR) for amplification. Often, the beta actin gene, which is constitutively
expressed in most cell types, is used either as an internal control to monitor reverse
transcription or as a reference to quantify target gene expression (Kinoshita et al. 1994).
One drawback to this method however, is that genomic DNA (gDNA)
contamination is inevitable during RNA isolation. The gDNA is co-amplified with
sscDNA when PCR is performed, and can lead to false positive results o f RT-PCR- This
problem can be solved using PCR primers spanning across introns o f the actin gene to
generate PCR products, which differ in size from the shorter cDNA product. To date,
only one partial sequence o f actin cDNA from the gills o f eastern oyster has been
reported (Unger and Roesijadi 1993). Furthermore, whether or not the actin gene
contains an intron is unknown. In order to use the gill actin gene as an internal control in
hemocyte RT-PCR, the first objective o f this study was to determine whether the gill
actin gene contains an intron and expresses in hemocytes. The second objective was to
evaluate the feasibility o f the transfer o f antimicrobial peptide genes controlled by a
cecropin B promoter to enhance oyster immunity. Because hemocytes are the defense
cells in oysters, the hemocyte number and hemocyte killing ability (index) were
measured. In addition, bacterial hemolymph loading, bacterial tissue loading and P.
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marinus tissue loading measurements were measured as indices for immunity
enhancement.

Materials and Methods
Oysters
Eastern oysters were collected at Grand Isle, Louisiana, and were maintained in a
recirculating system with ultraviolet-treated artificial seawater (Instant Ocean, Aquarium
Systems Inc., Mentor, Ohio) at 15%o salinity and 25° C at the Department o f Veterinary
Science, Louisiana State University Agricultural Center.

Hemolymph Collection
Oysters were notched at a point 2/3 o f the distance from the hinge along the shell
edge o f the dorsal lateral side. This site is near the adductor muscle sinus and is
convenient for collecting hemolymph or for plasmid injection. Hemolymph was
collected from the adductor muscle sinus using a 3-ml syringe and a 2S-G needle. To
avoid shearing hemocytes, hemolymph was slowly collected into syringe and discharged
into a 10-ml tube after the needle was removed. The hemolymph was placed on ice to
prevent aggregation o f the hemocytes.
PCR

DNA isolation: DNA was isolated using a QIAamp DNA tissue Mini kit (Qiagen,
Chatsworth, California), eluted with 30 pi o f distilled water, and stored at -20° C until
needed.

Primer design and synthesis: Optimal primer sets for amplifying target gene
sequences w ere designed using PC/Gene (Intelligenetics, Mount View, California) and
synthesized at the Gene Probe and Expression Laboratory, School o f Veterinary
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Medicine, Louisiana State University (Table 5-1). The purpose o f each primer set was as
follows: (1) OYR-1 and OYR-2 to amplify 291 bp o f the 28S rRNA gene for identifying
PCR inhibitors and the existence o f oyster DNA, (2) OY ACT-1 and OYACT-2 to
amplify 770 bp o f actin cDNA or the larger actin gDNA for detecting actin mRNA and
the actin intron, (3) GFP-5 and GFP-6 to amplify 539 bp o f the gene for red-shifted green
fluorescent protein (rsGFP) cDNA for detecting rsGFP mRNA, (4) VEC-1 and VEC-2 to
amplify 863 bp o f cecropin gDNA sequence for detecting cecropin B gDNA, (5)
CECRO-1 and FISH-2 to amplify 1200 bp LOKI-24 cassette for detecting LOKI-24 , and
(6) MCEP-1 and MCEP-2 to amplify 135 bp for detecting cecropin B mRNA.
Optim ization o f PC R: PCR reactions were performed in a 50 pi final volume
using a PTC-100™ Programmable Thermal Controller (MJ Research, Watertown,
Massachusetts). By optimizing the concentration o f magnesium (Perkin Elmer), dimethyl
sulfoxide (DMSOXSigma Chemical Company, St. Louis, MO), and the annealing
temperature, the optimal conditions for each primer set were obtained. For OYR-1, -2,
VEC-1, -2, OYACT-1, -2, CECRO-1 and Fish-2 primer sets, the optimal final
concentrations o f reagents were as follows: 10 pi (~ 0.01 pg) oyster gDNA, 0.5 pM o f
each primer, 0.01 mM deoxynucleotide triphosphates (dNTPs, Perkin Elmer, Foster City,
California), 0.25 mM M gCh, 1% (v/v) DMSO, 0.025 U AmpliTaq DNA polymerase
(Perkin Elmer), IX AmpliTaq buffer I (Perkin Elmer, 1.5 mM MgCfe, 50 mM KC1, 10
mM Tris-HCl, pH 8.3). Cycle conditions were as follows: denature at 95° C for 3 min
followed by 30 cycles o f denaturing at 95° C for 30 sec, annealing at 52° C for 1 min, and
extension at 72° C for 1 min. For primer set GFP-5 and GFP-6, the optimal final
concentrations o f reagents were as follows: 10 pi (-0.01 pg ) oyster DNA, 0.1 pM o f
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Table 5-1. The nucleotide sequences o f primer sets used in PCR and RT-PCR to detect
the existence and expression of target genes.
Prim er set
0>P)
OYR-1 (26)

Target
28S rRNA
gDNA

Amplified
base pair
291

OYR-2 (24)
OYACT-1 (20)

Actin
cDNA

770

rsGFP
cDNA

539

Cecropin
B gDNA

863

MCEP-2 (25)

5’-AGA-CTT-GAC-TCC-GCT-GCA-TAA-GTG-3 ’
5’-TAC-CGT-TTC-TGA-TGT-TGC-GAC-C -3’

LOKI-24
cassette

1200

FISH-2 (25)
MCEP-1 (26)

5 ’-GTC-AGT-GGA-GAG-GGT-GAA-GGT-GAT-GC A-AC -3 ’
5’-GAA-AGG-GCA-GAT-TGT-GTG-GAC-AGG-TAA-TG-3 ’

VEC-2 (22)
CECRO-1 (29)

5-AGA-ACC-ACC-GAT-CCA-GAC-GG-3’
5-ACA-CTT-TCT-ACA-ATG-AAC-TCC-GTG-3’

GFP-6 (29)
VEC-1 (24)

5 ’-GCT-AAA-TAC-TTC-CCG-AGT-CCG-ATA-GC-3 ’
5’-GAC-CCT-TCC-TCC -AGC-TCT-TCT-GAC-3'

OYACT-2 (24)
GFP-5 (29)

Primer sequences

5 ’-GCC-GGA-TCC-GTG-TAT-TCC-TGG-ACC-AAA-AA-3 ’
5’-TCT-CCT-GAT-GTA-GTG-GCG-TGT-GGT-C-3’

Cecropin
B mRNA

135

5’-CAG-AAC-C AA-AGC-GAA-CAC-GAA-GAA-AA-3 ’
5’-ATC-GCC-GGT-C AA-GCC-TTG-AC A-ATA-C-3 ’
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each primer, 0.01 mM dNTPs (Perkin Elmer), 0.02 U Vent® DNA polymerase (New
England Biolabs, Beverly, Massachusetts), IX ThermoPol Buffer (New England Biolabs,
10 mM KC1, 20 mM Tris-HCl, pH 8.8 at 25° C, 10 mM (N H ^ S O ^ 2 mM MgSO* 0.1%
Triton X-100). Cycle conditions were as follows: denature at 95° C for 3 min followed
by 30 cycles o f denaturing at 95° C for 30 sec, annealing at 63° C for 1 min, and extension
at 72° C for 1 min.

Analysis of PCR products: PCR products were analyzed using agarose gel
electrophoresis. Twenty pi o f each PCR product were mixed with 2 pi o f tracking dye
(0.25% bromophenol blue, 0.25% xylene cyanol FF and 30% glycerol in distilled water),
and electrophoresed in a 1% or 2% Tris-acetate (TAE, 0.04 M Tris-acetate, 1 mM
EDTA) agarose gel. The gels were electrophoresed at 5 volts/cm for 120 min, and
stained with 0.5 pg ethidium bromide/ml TAE for 15 min, de-stained in TAE for another
15 min and visualized with a UV transilluminator (Pharmacia Inc., Piscataway, New
Jersey). A digital camera (DC 120, Kodak, New York) was used to document the image
to be analyzed with an Electrophoresis Documentation and Analysis System 120
(Kodak).

Verification of PCR products: PCR products were verified by sequencing. PCR
products were separated on TAE agarose gel and stained with ethidium bromide as
described above. The gels were visualized with long wave UV light to avoid DNA
damage, and a band of the expected size band was excised with a sterile razor blade. An
agarose gel DNA extraction column (Qiagen) was used to recover DNA from the
agarose. A Cycle Sequencing Ready kit (Perkin Elmer) and an ABI Prism™ 310 Genetic
Analyzer (Perkin Elmer) were used to determine the DNA sequence. Final sequences
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were verified by comparison with published sequences using BLAST programs (Altschul
et al. 1997, Zhang et al. 1997) that are available at the internet web site o f the National
Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov).

RT-PCR
Total RNA isolation and decontamination of DNA: Total RNA was isolated
using an RNeasy mini column (Qiagen). Plasmid DNA or gDNA in total RNA was
eliminated using Deoxyribonuclease I (Life Technologies, Gaithersburg, Maryland).
Twenty-four pi o f total RNA were transferred to an RNase-free, 0.3 ml microcentrifuge
tube containing 3 pi o f 10X DNase I reaction buffer (200 mM Tris-HCl pH 8.4, 20 mM
MgCh, 500 mM KC1), 3 U o f DNase I, and incubated at 25° C for 15 min. DNase I was
inactivated at 65° C for 10 min in the presence o f 2.5 mM EDTA.

Reverse transcription (first strand complement DNA synthesis): First strand
cDNA was synthesized using Moloney Murine Leukimia Virus (M-MuLV) reverse
transcriptase First-Strand cDNA synthesis Kit (Phamacia) with minor modifications as
follow: 8 pi of DNA-free RNA was added to an RNase-free 0.3 ml micro-centrifuge tube,
heated 10 min at 65° C and chilled on ice to denature the RNA secondary structure. Five
pi o f Bulk First-Strand Reaction Mix, 1 pi DTT solution (200 mM), and 1 pi N ot 7-d
(T)is primer (0.2 pg) were added. The reaction was incubated at 37° C for 1 h to allow
mRNA to be transcribed to single strand DNA (ssDNA).
PCR amplification and verification of RT-PCR products: 15 pi o f the ssDNA
(above) was used as template for PCR. A primer set for the target gene was used and
PCR conditions for each primer set were as described above. Verification and
sequencing of RT-PCR products were the same as described above.
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Plasmids
The pPC-6 containing cecropin B genomic DNA included 621 bp o f cecropin B
promoter sequence and 1086 bp o f coding and non-coding sequence (Figure 5-1 A). The
pQZ-1 containing 621 bp o f cecropin B promoter sequence linked with rsGFP reporter
gene (Figure 5-1 BXZhang et al. 1998), pLOKI-24 contained a synthetic lytic peptide
gene, LOKI-24, controlled by the cecropin B promoter (Figure 5-1 CXCooper et al.
unpublished data).

Plasmid mini-preparations: Plasmids were prepared from 1 ml o f culture using
mini-preparation methods (Sambrook et al. 1989) and verified by digestion with the
proper restriction enzymes and agarose gel electrophoresis. One-ml aliquots o f culture
were frozen and stored at - 80° C, after the addition glycerol to a final concentration o f
20% .

Large scale plasmid preparation: Two ml o f culture were expanded to 200 ml
using LB medium with the proper antibiotic and incubated for 10 hours at 37° C with
shaking. The culture was expanded to 300 ml and incubated for an additional 8 hours. A
Qiagen-tip 500 column (Qiagen) was used to isolate plasmid DNA. Purity and
concentration were estimated by spectrophotometry (GeneQuant RNA/DNA calculator,
model 80-2104-98, Pharmacia Biotech, Cambridge, England). Plasmids were
resuspended in Tris EDTA buffer (10 mM Tris, 1 mM EDTAXTE, pH = 7.4) and stored
at -20° C for later use.
Hemocyte Number Determination
Ten pi o f hemolymph from each oyster were used for counting hemocyte
numbers. Hemocyte number was counted using a hemocytometer at 100 X magnification
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Figure 5-1. The structure o f transferred genes and their products. APR: acute phase
response cecropin B promoter. rsGFP: red shifted green fluorescent protein. Pre: pre
sequence of cecropin B. Pro: pro sequence o f cecropin B. LOKI-24: a synthetic
antimicrobial peptide gene containing 24 amino acid residues.
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with phase contrast microscopy (Optiphot-2, Nikon Inc., Garden City, New York).
Hemocyte number per ml hemolymph was calculated.
Hemocyte Killing Ability Assay
The hemocyte killing ability o f each oyster was measured using a tetrazolium dye
reduction assay (Volety et al. 1999). Vibrio vulnificus (1.2S x 106) was used as a target to
measure hemocyte killing. Briefly, hemolymph from each oyster was seeded at a density
o f 1 x 10s cells/well in 6 wells o f a 96-well flat-bottom plate so that each oyster could be
tested in triplicate; 3 hemocyte wells with bacteria and 3 hemocyte wells without
bacteria. Plasma was aspirated after the hemocytes attached to the bottom. After cell
attachment, 0.22 pm filtered artificial sea-water (FASW) was added to 3 o f the 6
hemocyte wells, 25 pi per well (Hemocytes only, H), and 25 pi o f FASW containing V
vulnificus (1.25 x 106) were added to the remaining 3 wells (Hemocytes w ith bacteria,
HB). In addition, 3 wells containing 25 pi o f FASW (Blank) and 3 wells containing
25 pi V. vulnificus (1.25 x 106/ 25 pi FASW) were used as controls. The plates were
incubated at 25° C for 3 h for killing to proceed. Thereafter, 100 pi o f nutrient broth plus
salt (3 g/L beef extract, 5 g/L peptone, and 20 g/L NaClXDIFCO Laboratories, Detroit,
Michigan) were added to each well and the plate was incubated at 37° C for 2 h to allow
the surviving bacteria to grow. To each well was added 20 pi o f MTS/PMS reagent
(Promega, Madison, Wisconsin) and the plates were incubated at 25° C for 30 min to
allow the color to develop. Absorbance (Abs) was measured at 490 nm using an ELISA
reader and the Abs o f the blank wells was subtracted. The killing index (K I) percentage
was calculated as 1 - [(Abs™-AbsH)/(Absv)] x 100.
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Bacteria Hemolymph Loading Assay
Drop dilutions were used for the bacteria hemolymph loading assay. One
hundred pi o f hemolymph from each oyster were serially diluted 10, 100 and 1000 x
using 900 pi FASW. Three drops (20 pl/drop) o f non-diluted and diluted hemolymph
were dropped separately on a marine agar plate (Difco Laboratories). Plates were
incubated at 25° C for 16 h for the growth o f bacteria colonies. The colony forming units
(cfu) per lOOpl hemolymph were calculated.

P. marinus Tissue Loading Assay
Each whole oyster meat was weighed and homogenized in a 50-ml tube
containing 20 ml o f FASW (Fisher and Oliver 1996). One ml o f the homogenized tissues
was transferred to a 20-ml tube containing 9 ml o f Ray’s fluid thioglycollate media in
triplicate tubes. Then, SO pi of chloramphenicol (25 mg/ml ethanolXSigma) were added
and mixed before an addition of 1 ml o f nystatin (1 mg/ml distilled waterXSigma), was
layered on the top without mixing. The tubes were incubated in the dark at 25° C for 7 d.
Thereafter, the tubes were centrifuged at 1,500 x g for 10 min and the supernatants were
discarded. For tissue degradation, 10 ml o f 2 M NaOH were added to each tube and
incubated at 60° C for 3 h followed by 3 washes with 10 ml o f distilled water and
centrifugation at 1,500 x g for 10 min. The parasite pellets were resuspended in 1 ml o f
Lugol’s solution (potassium iodide 2.4 mg/ml, iodine 1.6 mg/ml distilled water) and
mixed by vortexing for 1 min. One hundred pi o f Lugol’s solution containing parasites
were placed on filter paper (0.22 pm) and aspirated. The parasites stained a dark blue
color, were counted under 100 X magnification using a phase-contrast microscope
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(Optiphot-2, Nikon Inc., Garden City, New York). The number o f parasites per gram
tissue was determined.

Bacteria Tissue Loading Assay
Drop dilutions were used to determine bacteria tissue loading. One hundred |il o f
the supernatant o f homogenized tissues from each oyster were diluted to 10, 100 and
1000 X in 900 pi FASW. Three drops (20 p 1/drop) of undiluted or diluted supernatants
were plated separately on marine agar (Difco Laboratories). The plates were incubated at
25° C for 16 h for the growth o f bacteria colonies. The number o f colony forming units
(cfu) per ml o f supernatant was determined.
Study 1: Determining Whether the Gill Actin Gene Contains an Intron and
Expresses in Hemocytes
Polymerase chain reaction was performed on hemocyte gDNA using OYACT-1
and -2 primer sets that were designed to amplify a 770 bp fragment o f gill actin cDNA.
If the actin gene contained an intron between the primers, the size o f PCR products would
be expected to be greater than 770 base pairs (bp). PCR products were analyzed using a
1% TAE agarose gel. The actual size (bp) and sequence o f PCR products were
determined as described above. Meanwhile, RT-PCR was performed on total RNA
isolated from hemocytes to determine whether the gill actin gene was expressed in
hemocytes. The RT-PCR products were subjected to gel electrophoresis followed by
sequence determination of the target band excised from a gel. The sequence o f the band
was compared with gill actin cDNA.
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Study 2: Evaluating the Feasibility of the Transfer of Antimicrobial Peptide Genes
Controlled by a Cecropin B Promoter to Enhance Oyster Immunity
Before transfection: A total o f 60 oysters were randomly divided into 5 groups.
Each group contained 12 oysters. Each oyster was assigned a number o f one through
twelve. Three hundred pi o f hemolymph were collected from each oyster for measuring
hemocyte number, hemocyte killing, and bacteria hemolymph loading as described above
and the mean of each parameter o f each group was calculated.

Transfection: Oysters were transfected with pQZ-1, pPC-6, and pLOKI-24
plasmids using SuperFect™ (Qiagen), a commercial transfection reagent. Based on
preliminary studies, 10 pg o f each plasmid were mixed with SuperFect™ at a ratio o f 1:4
(pg/pl ) in 150 pi saline (0.48 g/L CaCl2, 1.45 g/L MgS0 4 , 2.18 g/L MgCl26H20 , 0.31
g/L KC1, 11.61 g/L NaCl, 0.35 g/L NaHCQj) and injected into the oyster adductor
muscle sinus. Each o f the five groups o f oysters received a different treatment (injection)
(Table 5-2). Transfected oysters were returned to the tanks 6 h after injection.

After transfection: Three days after transfection, hemolymph from each oyster
was collected for DNA, RNA, and functional peptide analysis. PCR was performed on
DNA isolated from hemocytes using a primer set (OYR-1 and OYR-2, Table 5-1) for the
28S rRNA gene as a positive control. Amplification o f 291 bp o f 28S rRNA indicated
the successful isolation o f hemocyte DNA. For the detection o f gene transfer into
hemocytes, primer sets specific to each transgene (Table 5-1) were used in PCR as
follows: GFP-5 and GFP-6 for rsGFP, VEC-1 and VEC-2 for cecropin B, CECRO-1 and
FISH-2 for LOKI-24.
RT-PCR was performed on pooled total RNA from each group for the detection
o f cecropin B mRNA. Oyster actin specific primers, OY ACT-land OYACT-2 (Table 51), were used as a positive control. Using primers, MCEP-1 and MCEP-2 (Table 5-1),
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Table 5-2. Experimental design for the evaluation of the effect of antimicrobial gene transfer on oyster immunity.
Oyster group
(12 oysters/group)

Treatments

Target gene in plasmid*

1

Saline

—

II

SuperFect

Purposes

Saline Control

SuperFect Control

Parameters evaluated for all groups

Detection of transferred target genes
by PCR
Detection of cecropin B mRNA
by RT-PCR

III

pQZ-1

Red shifted green
fluorescent protein (rsGFP)

Plasmid Control

The amount change
(after transfection - before transfection) o f :
1) hemocyte number.
2) hemocyte lulling index.
3) bacteria hemolymph loading.

IV

pPC-6

Cecropin B, a genomic
antimicrobial peptide gene
from moth.

Evaluate cecropin B
function

P. marinus tissue loading after transfection.

pLOKI-24

LOKI-24, a 24 amino acid
synthetic antimicrobial
peptide gene

V

Bacteria tissue loading after transfection.
Evaluate LOKI-24
function

* All target genes were controlled by an acute phase response promoter (from cecropin B gene).
- denotes no plasmid was transferred to the oyster group.

specific to cecropin B mRNA, RT-PCR can amplify a 135 bp band corresponding to
cecropin B mRNA. Amplification o f the 135 bp band suggests the transcription o f
cecropin B; RT-PCR was not conducted to detect the LOKI-24 mRNA due to the small
gene size (84 bp).
Hemocyte number, hemocyte killing index, and hemocyte bacterial loading were
measured. The amount change o f each parameter was calculated by subtracting the value
o f each parameter measured before transfection from the value o f each parameter
measured after transfection. Thereafter, oysters were used for P. m arinus tissue loading
and bacteria tissue loading assays described above and the mean o f each parameter o f
each group was calculated.
Data Analysis
For detecting significant differences among groups o f evaluated parameters, the
hemocyte number, hemocyte killing index, bacteria hemolymph loading, P. m arinus
tissue loading and bacterial tissue loading were analyzed. Due to the non-normal
distribution o f the data after transformation, the non-parametric Kruskal-Wallis test was
used to detect the significant different (P < 0.05).
Results
Study 1: D eterm ining W hether the Gill Actin Gene C ontains an Intron and
Expresses in Hemocytes
Based on agarose gel electrophoresis, PCR products from hemocyte gDNA and
RT-PCR from hemocyte total RNA were about 770 bp, similar to gill actin cDNA
(Figure 5-2). To distinguish gDNA from actin cDNA using agarose gel electrophoresis
was not possible. By DNA sequencing, the PCR product o f hemocyte DNA showed 726
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Figure 5-2. Agarose gel analysis o f PCR and RT-PCR products from hemocytes. Using
OYACT-1 and - 2 primer sets, PCR was performed on 10 ng genomic DNA (lane 1) and
total RNA digested with DNase I (lane 2), and RT-PCR was performed on the total RNA
digested with DNase I (lane 3). A 770 bp band in lane 1 indicates the actin gene was
amplified. No band was found in lane 2 indicating no genomic DNA contamination. A
band (-770 bp) in lane 3 indicates the actin mRNA was amplified. M: 100 bp marker,
PCR negative control without DNA.
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bp (not including 44 bp o f primer sequence), and 93% identity (agreement) with the
published gill actin gene cDNA (Table 5-3 A).
Gel analysis o f RT-PCR products o f total RNA showed similar size to PCR
products o f gDNA (Figure 5-2). The nucleotide sequence o f RT-PCR products o f
hemocyte RNA showed 726 bp and 100% homology when compared with the published
actin cDNA sequences (Table 5-3B), indicating that the actin gene was expressed in
hemocytes.

Study 2: Evaluating of the Feasibility of the Transfer of Antimicrobial Peptide
Genes Controlled by a Cecropin B Promoter to Enhance Oyster Immunity
The 28S rRNA gene w as amplified from all DNA isolated from oysters o f each
group (Figure 5-3 A to E). The results indicated successful DNA extraction and that PCR
performed as expected. Genes corresponding to rsGFP, cecropin B, and LOKI-24 were
not detected in oyster groups receiving saline (Figure 5-4 A; 5-5 A and 5-6 A) or
SuperFect™ only (Figure 5-4 B; 5-5 B and 5-6 B) but were detected in oysters
transfected with pQZ-1 (Figure 5-4 C), pPC-6 (Figure 5-5 C), and pLOKI-24 (Figure 5-6
C). In group III oysters transfected with pQZ-1 and group V oysters transfected with
pLOKI-24, rsGFP and LOKI-24 gene were detected in all 12 oysters o f each group
(Figure 5-4 C and 5-6 C). Since one oyster (the eleventh) died after transfection in group
IV, data from the eleventh oyster in each o f the other groups was excluded from data
analysis. The cecropin B gene was detected in all 11 oysters transfected with pPC-6
(Figure 5-5 CXTable 5-4). The PCR positive oysters indicated the plasmids were
retained in oysters hemolymph.
The mRNA o f cecropin B was not detected in the hemocytes o f pPC-6 transfected
oysters. No contamination o f actin genomic DNA (Figure 5-7 A) and cecropin B plasmid
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Table 5-3 A. Nucleotide sequence comparison o f PCR product and gill actin cDNA. The
identity (agreement) was 682/726 (93%).
?CR:

1

cDNA:

40

PCR:

61

cDNA:
PCR:
cDNA:
PCR:
cDNA:
PCR:
cDNA:
PCR:
cDNA:
PCR:
cDNA:
PCR:
cDNA:
PCR:
cDNA:
PCR:
cDNA:
PCR:
cDNA:
PCR:
cDNA:
PCR:
cDNA:

tagccccagaggagcaccccgtcctcctgaccgaggcccatctcaaccccaaggccaaca 60
1111111111111111II 1!111111 1111111 1I111 111I1I1111111111!11 1
tagccccagaggagcaccccgtcctcttgaccgaggccectctcaaccccaaggccaaca 99

gagaaaagatgacacagatcatgttcgaaaccttcaactctcccgccatgtacgtcgcca 120
1111I11111111111111111111111 111111I1111 111111111111i111I1 1
100 gagaaaagatgacacagatcatgttcgagaccttcaactcccccgccatgtacgtcgcca 159
121 tccaggccgtactgtccctgtacgcttccggtcgtaccactggtatcgtactcgactccg 180
111 1111 111111111111111111111111111 11111111111111111111111111
160 tccaggccgtactgtccctgtacgcttccggtcgtaccactggtatcgtactcgactccg 219
181 gagatggtgtgtcccacacagtccccatctacgagggatacgcccttccccacgccatca 240
111i111 111i1i1II1i111iiI1111 I1111i I11111 1i11111 1I111111111 1
220 gagatggtgtgtcccacacagtccccatctacgagggatatgcccttccccacgccatca 279
241 tgagattggatctcgctggacgtgatctgaccgattacctcatgaagatccttacagagc 300
111111111111111111111111111111111 1111 1111111111 111111I1111I1
280 tgagattggatctcgctggacgtgatctgaccgattacctcatgaagatccttacagagc 339
301 gtggttactctttcaccaccacagctgagagagaaatcgtcagagacatcaaggagaaac 360
1111111 11111111111I11111111 11111I11II 111111 111 1I111111 111 I
340 gtggttactetttcaccaccacagctgagagagaaatcgtcagagatatcaaggagaagc 399
361 tgtgctatgttgctttggactttgagcaggagatggccactgccgcatcatcatcatccc 420
1111111 111111111111111 11 I11111111 11111I 1I111 II 11111 111 1
400 tgtgctatgttgctttggacttcgagcaggagatggccacagccgcttcctcatcctccc 459
421 tagagaagagctacgaacttcccgacggtcaggtcatcaccattggcaacgagcgattca 480
1 11111 1II 11111111111111111111111111II 11!11111111111 111111 1
460 tggagaagagctacgaacttcccgacggtcaggtcatcaccattggcaacgaacgattca 519
481 ggtgcccagaggccatgttccagccatccttccttggtatggaatcctccggtatccatg 540
1111111 111111111111111111111111111111111 I11111 1 111111II11II
520 ggtgcccagaggccatgttccagccatccttccttggtatggaatccgccggtatccatg 579
541 aaaccacatacaacagtatcatgaaatgtgatgttgatatccgtaaagacttgtacgcca 600
1111 1 1111 1 11111111111 1111111 111111111111II 11111111 II 1
580 aaacatcataccaaagtatcatgaagtgtgatgttgatatccgtaaagacttgtatgcta 639
601 acacagtcttatctggtggttccaccatgtatcccggtattgctgaccgtatgcagaagg 660
1 1 III I I1111 III 1111II 111 II 11111 II III 1 1111111 111
640 atattgtcctctctggaggtaccaccatgttcccaggtatcaccgacagaatgcagaagg 699
661 aaatcacagctctagctcctagcacaatgaagatcaaggtcattgccccacccgagagga 720
II 111I 1 II 111111
1111111 111 111111111111111111111111111
700 aagtcaccaccctcgctcctccaacaatgaagatcaaggtcattgccccacccgagagga 759
721 aatact 726
1II1N1I
11
M
760 aatact 765
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Figure 5-3. Gel electrophoresis o f PCR-amplified products using a primer set for 28S
rRNA. The amplification o f 291 bp o f 28S RNA as a positive control for PCR and the
presence o f oyster DNA. Panel A: group I oysters transfected with saline. Panel B: group
II oysters transfected with Superfect™. Lane 1: positive control; lane 2: negative control
without oyster DNA; lane 3-8 and 10-15: 12 oysters in each group; lane 9: 100-bp
marker.
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Figure 5-3. Continued. Panel C: group III oysters transfected with pQZ-1. Lane 1:
positive control; lane 2: negative control without oyster DNA; lane 3-8 and 10-15: 12
oysters in each group; lane 9: 100-bp marker. Panel D: group IV oysters transfected
with pPC-6. Lane 1: positive control; lane 2: negative control without oyster DNA; lane
3: no sample loading to avoid cross contamination to negative control lane 2; lane 4-9,
11-14 and 16: 11 oysters in the group; lane 15: empty lane due the death o f the eleventh
oyster after transfection; lane 10: 100-bp marker.
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Figure 5-3. Continued. Panel E: group V oysters transfected with pLOKI-24. Lane 1:
positive control; lane 2: negative control without oyster DNA; lane 3-8 and 10-15: 12
oysters in each group; lane 9: 100-bp marker.
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Figure 5-4. Gel electrophoresis o f PCR-amplified products using a primer set for rsGFP
to identify the existence o f the rsGFP gene. The amplification o f a 539 bp band o f rsGFP
gene indicates the presence o f rsGFP gene. Panel A: group I oysters transfected with
saline. Lane 1: positive control; lane 2: negative control without oyster DNA; lane 3-9
and 11-15: 12 oysters in each group; lane 10: 100-bp marker. Panel B: group II oysters
transfected with Superfect™. Panel C: group III oysters transfected with pQZ-1. Lane 1:
positive control; lane 2: negative control without oyster DNA; lane 3: empty lane to avoid
cross contamination o f lane 2 to negative control; lane 4-9 and 11-16: 12 oysters in each
group; lane 10: 100-bp marker.
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Figure 5-5. Gel electrophoresis o f PCR-amplified products using a primer set for the
cecropin B gene to amplify an 863 bp band o f cecropin B indicating the presence o f
cecropine B gene. Panel A: group I oysters transfected with saline. Panel B: group II
oysters transfected with Superfect™. Panel C: group IV oysters transfected with pPC-6.
Lane 1: positive control; lane 2: negative control without oyster DNA; lane 3: empty lane
to avoid cross contamination o f lane 2 to negative control; lane 4-9, 11-16: 12 oysters in
the group; lane 10: 100-bp marker. Due to the death o f the eleventh oyster after pPC-6
transfection, lane 15 o f pane C containing no sample.

115

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

A
1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16

1

2

3

4

5

6 7

8

9 10 11 12 13 14 15 16

B

c

Figure 5-6. Gel electrophoresis of PCR-amplified products using primers for LOKJ-24 to
amplify 1200 bp o f the LOKI-24 gene cassette. Panel A: group I oysters transfected with
saline. Panel B: group II oysters transfected with Superfect™. Panel C: group V oysters
transfected with pLOKI-24. Lane 1: positive control; lane 2: negative control without
oyster DNA; lane 3: empty lane to avoid cross contamination to negative control lane 2;
lane 4-9, 11-16: 12 oysters in the group; lane 10: 100-bp marker.
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RT-PCR
positive

PCR
positive
Treatment

Hemocyte
number
(l0 4/ml)*

Hemocyte
lulling
index (%)•

Bacteria
hcmolymph
loading (lOcfu/
100 pi)*

E. marinus
tissue loading
(l04/g tissue) ••

Bacteria tissue
loading
(101 cfu/g tissue )**

28S
rRNA

rsGFP

Cep B

LOKI
-24

Actin

CepB

Saline

12/12

0/12

0/12

0/12

Yes

No

1.5 ±2.9

0.9 ±33

-0.7 ±1.1

2.2± 3.3

16.6 ±8.2

SuperFect™

12/12

0/12

0/12

0/12

Yes

No

0.7 ±2.0

-49 ±46

-3.5±8.1

1.3± 1.5

14.8 ±6.9

pQZ-1

12/12

12/12

—

—

Yes

No

0.8 ±3.0

- 53 ±31

22.5 ±70.1

3.8 ±6.6

14.1 ±11.1

pPC-6

11/11

—

11/11

—

Yes

No

0.8 ±2.6

-54 ±32

31.8 ±107.8

3.0 ±7.2

11.1 ±6.7

pLOKl-24

12/12

—

—

12/12

Yes

No

0.3 ±1.2

- 40 ± 41

0.2 ±1.1

3.1 ±6.3

12.8 ±5.9
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Figure 5-7. Gel analysis o f PCR and RT-PCR products from hemocyte total RNA. The
total RNA from each oyster within each group was pooled, digested with DNase and
subjected to PCR with primers specific to actin (Panel A) and cecropin B (Panel B). RTPCR was performed on the total RNA o f 5 groups o f oysters with primers specific to
actin and cecropin B mRNA (Panel C). Amplification o f a 770 bp band from actin PCR
or a 863 bp from cecropin B PCR indicates the contamination o f genomic DNA or
plasmid DNA o f pPC-6. Amplification o f a 770 bp band from actin RT-PCR indicates
the successful o f RT-PCR. Amplification of a 135 bp from cecropin B RT-PCR indicates
the transcription o f cecropin B gene. M: 100 bp marker. +: positive control o f PCR
using 0.1 |ig oyster DNA (Panel A) or 1 ng pPC-6 (Panel B). —: negative control without
DNA (Panel A and B) or total RNA (Panel C). I: group I oysters transfected with saline.
II: group II oysters transfected with SuperFect. Ill: group III oysters transfected with
pQZ-1. IV: group IV oysters transfected with pPC-6. V: group V oysters transfected
with pLOKI-24.
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RT-PCR
IV
V

DNA (Figure 5-7B) was detected in total RNA after DNase I digestion. RT-PCR
successfully amplified the actin mRNA from total RNA in all five groups indicating the
success o f RT-PCR but the mRNA o f cecropin B was not found (Figure 5-7 CXTable
5-4).
For the hemocyte number assay, no significant difference (P < 0.05) was found in
hemocyte numbers among the five groups before and after transfection. Before
transfection, the hemocyte numbers o f individual oysters showed high variability in
group IV (receiving pPC-6X2.0 ± 1.7 x 106 cell/ml, range = 6.0 x 106), and in group V
(receiving pLOKI-24X19 ± 1.2 x 106 cell/ml, range = 4.1 x 106). After transfection, the
hemocyte number o f each oyster group increased. The hemocyte number in the saline
transfected group showed the largest increase o f 1.5 ± 2.8 x 106 (range = 10.5 x 106) from
1.5 ± 0.8 x 106 cell/ml to 3.0 ± 2.7 x 106 cell/ml but no significant difference was found
among five groups (Figure 5-8XTabIe 5-4 and 5-5). The percent change in hemocyte
killing among the five groups showed no significant difference. The hemocyte killing
index o f each group before transfection was about the same (68 ± 34%, range = 84% for
SuperFect™ transfected group, 70 ± 33%, range = 77% for pQZ-1 transfected group, 68
± 28%, range = 73% for pPC-6 transfected group, 66 ± 24%, range = 75% for pLOKI-24
transfected group), except for the saline group which showed low activity (39 ± 28%,
range = 90%)(Figure 5-9). After transfection, the hemocyte killing index o f the saline
transfected group remained constant (40 ± 30%, range = 90%) while those o f other
groups showed a 40% to 55% decrease (Figure 5-9XTable 5-4 and 5-5).
For the bacteria hemolymph loading assay, no significant differences (P < 0.05) in
the percentage change o f bacteria hemolymph loading were found among oyster groups.
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Figure S-8. Comparison o f the effect of antimicrobial peptide gene transfer on oyster
hemocyte number (n = 11).
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Mean ±
Standard
Deviatioa

Range

Minimum

Maximum

Coefficient of
Variation
(* /.)

Saline

1.5 ±2.8

10.5

-0.9

9.7

187

SuperFect™

0.7 ±2.0

72

-0.7

6.5

286

pQZ-l

0.8 ±3.0

11.1

- 1.9

9.3

375

pPC-6

0.8 ±2.6

10.8

1
oe

Table 5-5. Summary o f evaluated parameters o f each treatment (n = 11).

7.0

325

pLOKI-24

0.3 ± 1.2

3.6

- 1.4

2.2

400

0.9 ±32.7

125.5

-74.7

50.8

3633

SuperFect™

-48.9 ±46.4

134.7

-92.7

42.0

-95

pQZ-1

-52.6 ±30.8

78.2

-85.4

-7.2

-59

pPC-6

-54.5 ±32.1

86.5

- 83.2

3.3

-59

pLOKI-24

-40.2 ±41.1

147.4

-85.4

62.0

-102

Parameters/Treatments
Hemocyte number (IO*ceH/mI)*

Hemocyte killing index (*/•)*
Saline

Bacteria hemolymph loading ( l i f cfa/KW pi)*
Saline

-0.7 ±1.1

3.0

-2.8

0.2

-157

SuperFect™

-3.5 ±8.1

23.8

-21.7

2.1

-231

pQZ-1

22.5 ±70.1

236.3

t+i

o
i

233.3

312

pPC-6

31.8 ±107.8

368.9

-12.3

356.6

339

0.2 ±1.1

4.4

- 1.7

2.8

550

pLOKI-24

P. Marinus tissue loadina (Mfta tissuel**
Saline

2.2 ±3.3

10.4

0.002

10.4

150

SuperFect™

1.3 ±1.5

4.7

0.0009

4.7

115

pQZ-1

3.8 ±6.6

22.7

0.008

22.7

174

pPC-6

3.0 ± 7.2

242

0.0004

24.2

240

pLOKI-24

3.1 ±6.3

21.4

0.0002

21.4

203

Bacteria tissue loading (10>cfii/g tissue)**
Saline

16.6 ±8.2

29.4

4.2

33.6

49

SuperFect™

14.8 ±6.9

24.1

4.2

28.4

47

PQZ-1

14.1 ±11.1

36.6

2.3

39.0

79

pPC-6

11.7 ±6.7

20.3

2.0

22.3

57

pLOKI-24

12.8 ±5.9

18.4

3.2

21.6

46

* indicates the amount change by subtracting the value before transfection from the value
after transfection).
** indicates after transfection.
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Figure 5-9. Comparison of the effect o f antimicrobial peptide gene transfer on oyster
hemocyte killing index (n = 11).
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Highly variable bacteria hemolymph loading was found among all oysters within each
group. The most variable bacteria hemolymph loading was found in pPC-6 group before
transfection (1.3 ± 3.5 x 108cfii/100 pi hemolymph, range = 12.3 x 108). The change o f
bacteria hemolymph loading increased in the pQZ-1 transfected group (22.5 ± 70.1 x 10s,
range = 236.3 x 108), pPC-6 transfected group (31.8 ± 107.8 x 108 cfu/100 pi
hemolymph, range = 368.9 x 108) and pLOKI-24 (Figure 5-10XTable 5-4 and 5-5).
For the P. m arinus tissue loading assay, no significant decrease (P < 0.05) o f P.
m arinus tissue loading was found among groups. The pQZ-1 transfected oyster groups
showed the highest P. m arinus loading (3.8 ± 6.6 x 106 /g tissue, range = 22.7 x 106),
while the SuperFect™ injected group showed the lowest P. m arinus loading (1.3 ± 1.5 x
106 cfu/g tissue, range = 4.8 x 106) than other groups (Figure 5-11 AXTable 5-4 and 5-5).
For the bacteria tissue loading assay, no significant decrease (P < 0.05) o f bacteria
tissue loading was found among groups but the bacteria tissue loading decreased in pPC6 (11.1 ± 6.7 x 103 cfu/g tissue, range = 20.3 x 103) and pLOKI-24 (12.8 ± 5.9 x 103 cfu/g
tissue, range = 18.4 x 103) transfected groups compared to the saline injection group
(16.6 ± 8.2 x 103 cfu/g tissue, range = 29.4 x 103), SuperFect™ transfected group (14.8 ±
6.9 x 103 cfu/g tissue, range = 24.1 x 103), and pQZ-1 transfected group (14.1 ± 11.1 x
103 cfu/g tissue, range = 36.6 x 103)(Figure 5-11 B and 5-12XTabIe 5-4 and 5-5).

Discussion
Analysis o f actin genes to determine intron location and tissue expression patterns is
important if using actin as an internal control for mRNA quantification, reverse
transcription and cDNA library construction. Meanwhile in vivo antimicrobial peptide
gene transfer might facilitate the development o f disease resistance oysters.
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125
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

15

3
£
jp

10

5

2
0
SaNm

pLOKI-24

30

3
£

I
O

;
1

ill
iiiiii-iii
Sain*

pQZ-1

Figure 5-11. Comparison o f the effect of antimicrobial peptide gene transfer on
P erkinsus m arinus tissue loading (A) and bacteria tissue loading (B) (n = 11).

126
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

•
3
M
(A
9
Cl

30000-

€
o»
c
T3

to

O

20000-

3

m
M
to

10000-

to
(D

Salino

SuporFoct

pQZ-1

pPC-6

pLOKI-24

treatm en t

Figure 5-12. Comparison o f the effect of antimicrobial peptide gene transfer on bacteria
tissue loading. Square with bar indicates mean and standard deviation (n = 11) o f each
oyster group. Circle indicates mean o f individual oysters from three replicates.

127
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

In Study 1, data indicated that the gill actin gene might not contain an intron and
was expressed in hemocytes. An actin-like gene, which might be an actin gene isoform
without an intron, was amplified from gDNA. These results suggested that the partial
actin gene sequence used in this study might not contain an intron. Although all
sequenced vertebrate actin genes contain introns at amino acid residues 43, 270, and 330,
the number and location o f introns in invertebrate actin genes vary. For example,
drosophila has 6 isoforms o f actin genes. Isoforms 2 and 5 contain no intron (Fyrberg et
al. 1981). Thus, for invertebrates, identification o f the actin intron is needed before using
an actin isoform as an internal control o f RT-PCR. Meanwhile digestion o f RNA with
DNase I to eliminate the contaminated gDNA is required to avoid a false positive o f actin
RT-PCR when the actin gene or isoform actin genes contain no intron.
The tissue expression patterns o f isoform actin genes (alpha, beta and gamma) are
different in vertebrates and invertebrates. In vertebrates the alpha isoform actin genes are
expressed only in muscle while beta cytoplasmic isoform actin genes are expressed in
most tissues (Kabsch and Vandekerckhove 1992). Although the cytoplasmic and muscle
actin o f vertebrates can be distinguished by analyzing actin amino acid sequences, this is
not possible in invertebrates (Vanderkerckhove and Weber 1978). Since the actin gene
from gill was also expressed in hemocytes, the actin gene might be a cytoplasmic actin
gene that is expressed in most tissues. Therefore, the gill actin gene can be used as a RTPCR internal control for non-muscle tissues such as hemocytes.
Furthermore, the results o f Study 2 is the first report on transferring of exogenous
antimicrobial peptide genes into oysters to study their effect on oyster immunity. The
results o f the bacteria tissue loading assay indicated that treatments receiving
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antimicrobial peptides genes had fewer bacteria than those o f the control groups though
no significant difference was found at P < 0.0S and P < 0.2 after log transformation o f
data.
PCR results from hemocyte DNA indicated that oyster hemocytes retained the
transferred genes at least 3 days after transfection. However, RT-PCR results from
hemocyte total RNA did not show detectable levels o f cecropin B mRNA, despite the
observations that bacteria tissue loading decreased in oyster groups transfected with
antimicrobial peptide genes. The unstable cecropin B mRNA might be one possible
explanation for the absence o f cecropin B mRNA in hemocytes. The 3’ end untranslated
mRNA sequence (UUAUUUAU) present in the cecropin B gene and most known
interlukins, tumor necrosis factor, human and mouse granulocyte-marcrophage colony
stimulating factors (GM-CSF) can cause the rapid degradation o f the mRNA (Kruys et al.
1994). RT-PCR on a series o f samples taken at different times after transfection needs to
be performed to determine the time course o f cecropin B gene expression.
On the other hand, cecropin B and LOKI-24 might be expressed as functional
peptides in other transfected tissues. For example, the cecropin B (APR) promoter was
found to function not only in channel catfish hemocytes but also in fibroblast cells
(Zhang et al. 1998). These results suggest that the APR promoter can function in other
tissues. The decrease o f bacteria tissue loading might be due to production o f cecropin B
and LOKI-24 peptides from other transfected tissues, which were not examined in this
study. The effects o f these peptides however, might be limited to extracellular bacteria.
The decrease in bacteria tissue loading was not likely caused by an increase in
hemocyte number, since the hemocyte number o f each group increased after transfection.
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Despite the increase in hemocyte number in the gene transfer groups, the increase was
about the same or smaller than that o f the control groups (Table 5-2). Moreover, the
hemocyte killing indices increased in saline transfected group oysters while other oyster
groups showed a decrease o f 40% to 55% in hemocyte killing (Table 5-2). Whether
human pathogenic bacteria loading, i.e. Vibrio sp. decreased while total bacteria loading
decreased, remains to be investigated by using a selection medium for Vibrio.
The gene transfer process affected oyster hemocyte numbers, the hemocyte killing
index and bacteria hemolymph loading. An increase in hemocyte numbers in each group
after transfection indicated that hemocytes in circulation increased. This might be due to
the migration o f tissue hemocytes to hemolymph (Oubella et al. 1993) or the proliferation
o f hemocytes. The 40% to 50% decrease o f hemocyte killing ability in transfected
oysters implied that the reduced activity o f hemocytes (Figure 5-9) was due to the toxic
|

effect o f transfection reagent, which was observed in in vitro transfection assays.
However, in time, the hemocyte killing ability might recover from the toxic effects o f
transfection. This could be demonstrated by a longer study with increased sampling
points.
In addition to the decreased hemocyte killing index, plasma and proteases might
play a role in increased bacteria hemolymph loading. The antimicrobial activity o f
PHOR-21, a synthetic antimicrobial peptide containing 21 amino acid residues, was
found to be significantly decreased by oyster plasma (La Peyre et al. 1998a). The
minimum inhibitory concentration (MIC) o f PHOR-21 against Vibrio vulnificus increased
from 1.56pM with no oyster plasma to 25 pM in the presence of oyster plasma. One o f
the major serum components found to inhibit antimicrobial activity was identified as a
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low-density lipoprotein (Peck-Miller et al. 1993). In plants, the endogenous serine
protease o f tobacco leaf was shown to degrade cecropin B peptides (Florack et al. 1995).
Moreover, exogenous proteases (virulence factors) from pathogens such as P. m arinus
could reduce the efficacy o f PHOR-21 against P. m arinus (La Peyre et al. 1998a). Since
oysters used in this study were infected with P. m arinus, oyster plasma and P. m arinus
proteases might have played a role in further diminishing the antimicrobial activities of
cecropin B and LOKI-24 peptides.
The question remains as to why the bacterial tissue loading decreased but not the
P. m arinus loading in this study. The most probable explanation was that a higher
concentration o f lytic peptide was needed to kill o r inhibit the growth o f Perkinsus. The
in vitro results o f antimicrobial peptide toxicity to bacteria and protozoa support this
explanation. For example, the MIC of PHOR-21 against Vibrio vulnificus was in the
range o f 1.56 to 3.12 pM while 50 pM was needed to kill 100% o f P. m arinus (La Peyre
et al. 1998a). Moreover, the MIC of tachyplesin I, an antimicrobial peptide from blue
crabs, for bacterial pathogenic Vibrio spp. ( Vibrio alginolyticus, V. anguillarum , and V
harveyi), was between 0.4 and 1.6 pg/ml while 500 pg/ml o f tachyplesin I was needed to
kill 62% o f P. m arinus (Morvan et al. 1997). It was previously reported that 10 fold
lower concentrations o f antimicrobial peptide were required to kill bacteria as opposed to
protozoan parasites (Jaynes et al. 1988). In this study, the peptide production might be
limited and the concentration of antimicrobial peptide in transfected tissues was enough
to decrease the bacteria load but not the P. m arinus load. Improvement o f transfection
efficiency might increase the production o f lytic peptides to a concentration to kill or
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inhibit the growth o f P. marinus. Or when toxic effects o f transfection ceased (longer
wait), there may be more cells to produce lytic peptides.
The highly variable physiological and immunological condition among individual
oysters hindered detection of a significant difference among groups for the evaluated
parameters. In this study, each parameter differed among oysters, regardless o f the
treatment. In evaluating eastern oyster hemocyte killing indices o f bacteria, a large
fluctuation was found even though 10 oysters were pooled per sample and contained 3
replicates o f pooled samples (Genthner et al. 1999). The highly variable killing index for
Vibrio parahaem olyticus was 16 ± 10% compared to Listeria m onocytogenes strains,
which was 18 ± 14% (Genthner et al. 1999). In the study with whole oyster P. marinus
loading, variability was found regardless o f how the oysters were infected, whether
natural or experimental (Faisal et al. 1999). The mean o f P. m arinus tissue loading for
wild oyster populations was 10.9 ± 30.7 x 106 parasite/g tissue (n = 25, range = 1.53 x
108). Likewise, P. m arinus free oysters which were then artificially infected with P.
m arinus, demonstrated highly variable parasite loading among individuals, with a mean
o f 3.2 ± 4.7 x 105 parasites/g tissues (n = 15, range = 1.6 x 106). In a study of
environmental and disease factors affecting mussel M ytilus galloprovincialis circulating
hemocytes, a high level o f variability was seen (Carballai et al. 1998). The mean
hemocyte number was 3.3 ± 0.10 x 106 hemocytes/ml (n = 540, range = 15.4 x 106). Due
to the variability o f the evaluated parameters within groups in our studies, detecting a
significant difference among groups is difficult unless the treatment induced a large
amount o f change in the evaluated parameters.
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To summarize our findings, oysters retained transferred genes in the hemocytes,
and the transfection process led to an increase in circulating hemocytes but decreased the
hemocyte killing ability for the duration o f this study. Although the presence of cecropin
B mRNA in hemocytes was not detected, the bacteria tissue loading decreased in oysters
transfected with antimicrobial peptide genes. The results o f this study are the first report
to suggest the feasibility o f enhancing oyster immunity and reducing bacteria loading
with the transfer o f antimicrobial peptide genes. Further studies should include the
design o f antimicrobial peptide genes for optimal expression in oysters. Factors leading
to inadequate production o f functional lytic peptides might be at the level o f transcription,
translation or post-translation modification o f lytic peptide genes. Control o f gene
transcription by a promoter was discussed in Chapter 4. Translational and posttranslational modifications are discussed below.
At the translation level, the use o f genes from different animal species might stall
translation due to rare codons used in the gene. For example, introduction o f rare codons
in yeast caused a dramatic decline o f gene expression (Hoekema et al. 1987). Oyster
codon usage (which can be obtained at the worldwide web site o f the Kazusa DNA
Research Institute, Japan, (http://www.kazusa.or.jp/codon/) is needed to design
transgenes for oyster cells.
At the post-translational modification level, the pre-pro-cecropin B peptide might
not function at an optimal level. There was a 22 amino acid pre-peptide sequence (signal
sequence) followed by a 4 amino acid pro-peptide sequence at the amino terminus (Nterminus) o f cecropin (Figure 5-1 B). The signal sequence is for directing the peptide to
the endoplasmic reticulum (ER) for secretion. There, the signal sequence is cleaved by a
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signal peptidase contained in the ER (Boman et al. 1989). The pro-sequence contains
sub-cellular targeting information and keeps the antimicrobial peptide inactive before
reaching its final destination, such as a phagosome or hemolymph (Valore et al. 1996).
The pro-sequence is removed by dipeptidyiaminopeptidase found at the target site for the
antimicrobial peptide to activate it for full function (Kreil 1990). Although the pre-prosequence of cecropin B had been used to direct the secretion o f cecropin and cecropin
analogs in Sf9 insect cells (Choi 1996) and the secretion o f cytosolic plant proteins in
plant cells (Denecke et al. 1990), whether or not the pre-pro-sequence o f cecropin B can
be recognized by oysters needs to be determined for further improvement o f the
antimicrobial peptide secretion and sub-cellular targeting studies, or the identity o f an
oyster pre-pro-sequence must be determined.
Once the pre-pro-peptide was processed into a functional peptide, the
antimicrobial activities could be affected by host factors such as pH, salt, and serum.
These factors might decrease the activity of antimicrobial peptides and led to difficulty in
detecting significant changes in the parameters being evaluated. The pH tolerance o f
cecropin B and LOKI-24 peptides require further evaluation. Antimicrobial peptides
might be pH sensitive, for example at pH S.S to 8.0 no effect was seen on the MIC o f
PHOR-21 against Vibrio vulnificus (La Peyre et al. 1998b). Therefore, PHOR-21 could
be expressed in the oyster hemolymph (pH 7.6) and still remain active (Boyd and Burnett
1996). On the other hand, cla vanin, a pH sensitive lytic peptide from tunicate, Stye la
clava, hemocytes showed higher antimicrobial activity at pH S.S than at pH 7.4 (Lee et
al. 1997). The low optimal pH o f clavanin made it one o f the best candidates for
expression in oyster phagosomes, where the pH value is between 3.1 and 4.9 (Beaven and
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Paynter 1999). The low pH in phagosomes can enhance clavanin activity while higher
pH outside phagosomes or cells can reduce the clavanin toxicity to host cells (Lee et al.
1997). Therefore, reduction o f P. marinus loading in oysters might be achieved more
effectively using a lysosome oriented signal peptide sequence to direct pH insensitive
antimicrobial peptides such as PHOR-21 or those that prefer low pH such as clavanin to
lysosomes which fuse with phagosomes where P. m arinus resides.
Finally, sensitivity o f antimicrobial peptides to salt becomes an important factor
to be considered due to the oyster’s seawater environment. Although salt sensitivities o f
cecropin B and LOKI-24 were not evaluated, salt might affect their antimicrobial activity.
The minimum concentration o f PHOR-21 to inhibit the growth o f Vibrio vulnificus
increased 8 fold from 0.78 jjM, at a salinity o f 6 %o, to 6.25 pM, at a salinity o f 30 %o (La
Peyre et al. 1998b). The antimicrobial activity of other peptides such as mouse and
human beta-defensin-1 were reduced by salt (Tager et al. 1998, Bals et al. 1998). In
contrast to salt sensitive PHOR-21 and beta-detensin-1, 5.9 to 17.2 %o NaCl
concentrations did not significantly affect the antimicrobial activity o f clavanins from
tunicates that reside in seawater (Lee et al. 1997). The results o f our studies implied that
disease resistance o f oysters could be enhanced, by transferring a properly designed lytic
peptide gene.
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CHAPTER 6 SUM M ARY AND CONCLUSIONS
The eastern oyster industry is economically important to the east coast o f the
United States. In addition to over fishing and the degradation o f the habitat, diseases
have caused a decline in oyster production. Traditional genetic improvements in oyster
strains to enhance disease resistance have been conducted with limited success, while in
vitro studies o f disease are hampered by the lack o f a well established cell culture system
and cell line. Development o f an optimal oyster cell culture system and cell lines have
long been recognized as urgent and essential for disease studies. However, no systematic
approaches have been conducted. Therefore, limited progress has been made during the
past 40 years (Rinkevich 1999).
The goal o f this work was to evaluate the feasibility o f using antimicrobial
peptide gene transfer to enhance oyster immunity. Included in this dissertation is the
work that paves the road to reach that goal. First, a systematic approach was used to
develop two basic needs for cell culture—tissue dissociation and cell cryopreservation.
Second, based on the above results, an in vitro, serum-free gene transfer system was
established. Third, the promoter o f snail heat shock protein 70 gene and the promoter o f
insect cecropin B gene were evaluated using this gene transfer system. Fourth,
antimicrobial genes controlled by the cecropin B promoter were transferred into juvenile
oysters to evaluate their effects on oyster immunity.
Dissociation o f tissue into individual cells is the first step to initiate cell culture,
however, a systematic comparison o f dissociation enzyme efficiency was not available.
In the effort to address this, the dissociation efficiency o f collagenase, pronase, and
trypsin were compared in Chapter 2. Using cell number, cell viability, cell yield, and cell
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dehydrogenase activity as parameters and repeating the experiment at least five times,
pronase was found to be statistically the best among these enzymes to dissociate atrial,
ventricle, and mantle tissues. This result indicated that enzymes such as collagenase and
trypsin, usually used to dissociate vertebrate tissues, are not the best to dissociate oyster
tissues. Meanwhile, this was the first quantitative comparison o f enzyme dissociation
efficiency and it set the foundation for further cell culture studies, such as the
development o f cell lines and in vitro gene transfer.
The conditions for cryopreservation o f the dissociated atrial and ventricle cells
were reported in Chapter 3. In order to preserve the dissociated cells for further studies,
cryoprotectants were screened, and freezing rates and thawing temperatures were
compared. The optimized cryopreservation conditions were 1) 10% glycerol, freezing at
medium rate and thawing at 45° C for atrial cells, and 2) 10% glycerol, freezing at
medium rate and thawing at 25° C for ventricle cells. These conditions are the first to be
reported for preserved somatic oyster cells.
In addition to developing cell isolation and cell cryopreservation conditions, the
establishment o f an in vitro gene transfer system is required for studies o f gene function
such as gene regulation. In Chapter 4, the first serum-free gene transfer system was
established. By using this system, the function o f the snail heat shock 70 promoter
(SHSP-70) and cecropin B promoter was evaluated. Optimal conditions to activate
SHSP-70 by heat shock (stress) were developed, however, addition o f LPS and IL-alpha
did not appear to induce the cecropin B promoter. Further studies on the cecropin B
promoter are needed.
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In Chapter S, the in vivo transfer o f an antimicrobial peptide gene was conducted
to evaluate the effect on oyster immunity. Although no significant difference was found
among evaluated parameters, bacteria tissue loading o f oysters receiving antimicrobial
genes was lower than that o f controls. These results imply that antimicrobial peptide
gene transfer to enhance oyster diseases resistance is feasible.
The most significant achievement o f this work was the establishment o f a gene
transfer system for oyster ventricle cells which are cultured in serum-free medium. Sera
contain undefined components and the components o f serum vary from lot to lot (Bjare
1992). Therefore, the results o f studies using serum-free medium will be more reliable
than those using a medium that contains serum (Bjare 1992). This gene transfer system
will benefit further oyster studies including the screening of functional promoters,
evaluating the function o f potential disease resistance genes, identifying disease
resistance genes from oysters, identifying virulence genes o f oyster pathogens, studying
the interaction between oyster cells and pathogens at the gene level, producing valuable
peptides using oyster cells as bio-reactors, and monitoring environment pollution using
oyster cells as bio-sensors.
By applying the knowledge o f oyster cell in vitro studies, disease problems may
be resolved by transferring antimicrobial peptide genes. Other quantitative phenotypes
such as growth rate and quality phenotypes, such as nutrition value, may also be
improved. However, the issues o f food safety and ecological impact o f transgenic oysters
need to be carefully evaluated. The addition o f extra genes into the oyster may alter other
gene expressions and may lead to the change o f protein compositions o f oyster meats.
Whether the change o f protein composition is toxic or allergenic to humans must be
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assessed. The potential negative impact o f transgenic oysters on ecological system may
be a problem because containment o f cultured transgenic oysters is not possible
compared to containment o f transgenic animals in a land habitat. The evaluation o f
aquatic transgenic animal impact on an ecological system, such as cross breeding with
other species is not possible. One o f the strategies to minimize the impact on an
ecological system is to produce sterile transgenic oysters by chromosome manipulation,
radiation exposure, or deletion o f the genes involved in gamete formation.
The acceptance o f transgenic oysters by consumers should be emphasized,
because the genetic improvement o f animals by transgenic techniques developed during
the last 20 years, is relatively new compared to the traditional breeding and selection
technique developed thousands o f years ago. Consumer awareness about transgenic
techniques as well as environmental and food safety issues with transgenic animals,
should be conducted in parallel with the development of transgenic animals as food.
In conclusion, the work o f this dissertation developed an in vitro system that
allows oyster studies to be conducted at the gene level. However, the hypothesis o f
adding an antimicrobial peptide gene to enhance oyster immunity cannot be validated,
due to the high variation o f the physiological condition of the oyster. Further in vitro and
in vivo research is needed.
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APPENDIX A COMPOSITION OF DECONTAMINATION SOLUTION USED
FOR TISSUE DECONTAMINATION
Antibiotic

Concentration (per/L)

Penicillin

500 units

Streptomycin

500 mg

Gentamycin

250 mg

Kanamycin

500 mg

Neomycin

250 mg

Chloramphenicol

25 mg

Polymyxin B

250 mg

Erythromycin

28 mg

Amphotericin B

28 mg
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APPENDIX B COMPOSITION OF SALINE I AND SALINE II USED FOR
DISSOCIATION SOLUTIONS
Ingredient

Saline I (g/L)

Saline D (g/L)

CaCl2

0.480

M gS04

1.456

M rCI26H20

2.182

NaCl

11.611

16.600

KC1

0.310

0.595

NaHCOa

0.350

0.666

Glucose

.

0.555

Galactose

.

0.111
0.111

Trehalose
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APPENDIX C COMPOSITION OF JL-OPRD-4 MEDIUM
All chemicals were purchase from Sigma Chemical Co. St. Louis, Missouri unless
otherwise indicated.
Table C -l. Preparation o f 500 ml JL-ODRP-4 medium
N um ber
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
* Refer to

Solutions

Balanced salts solution*
Trace solution 1*
Trace solution 2*
Essential amino acid solution (Gibco BRL,
Gaithersburg, Maryland)
Non-essential amino acid solution (Gibco
BRL)
Amino acid solution*
Nucleotide / Coenzyme A solution*
R P M I1640 vitamin solution
Carbohydrate solution*
Defined lipid solution (Gibco BRL)
Glutathione solution*
Aprotinin solution*
SPIT solution
Chloramphenicol *
Hepes solution
Table C-2

Volume
(ml)
454.0
0.5
0.5
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5.0
5.0
5.0
1.0
3.0
5.0
5.0
0.5
0.5
5.0
5.0
5.0

Table C-2. Components o f solutions for the JL-OPRD-4 preparation.

Solution

Components

Concentrations

Balanced salt/ buffer
solution
CaCl2
MgS04
MkC12. 6H20
KCl
NaCl
NaHCOj
Na2H P04. 7H20

360.0 mg/L
1092.0 mg/L
1637.0 mg/L
233.0 mg/L
8708.0 mg/L
350.0 mg/L
28.0 mg/L

Ferrous sulfate
Zinc sulfate

83.4 mg/100 ml
14.3 mg/100 ml

Cupric sulfate

24.9 mg/100 ml

Trace solution 1

Trace solution 2
Amino acid solution
Alanine
Glycine
Serine
Taurine
Glutamine

1000.0 mg/100 ml
500.0 mg/100 ml
500.0 mg/100 ml
1500.0 mg/100 ml
500.0 mg/100 ml

Nucleotide/Coenzyme A
solution
Adenosine 5’Monophosphate
Cytidine 5’Monophosphate
Uridine 5’-Triphosphate
Coenzyme A

20.0 mg/40 ml
20.0 mg/40 ml
20.0 mg/40 ml
20.0 mg/40 ml

Carbohydrate solution
5.0 g/100 ml
1.0 g/100 ml
1.0 g/100 ml

Glucose
Trehalose
Galactose
Glutathione solution
Glutathione (reduced)

100.0 mg/100 ml

Aprotinin

618.5 KU/100ml

Chloramphenicol

50.0 mg/100 ml

Aprotinin solution
Chloramphenicol
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APPENDIX D COMPOSITION OF LA-3 MEDIUM
Ail chemicals were purchase from Sigma Chemical Co. St. Louis, Missouri unless
otherwise indicated.
Table D -l. Preparation o f 500 ml LA-3 medium

Number

Solutions

Volume (ml)

1
Balanced salts/buffer solution*
2
MEM essential amino acid solution
3
MEM non-essential amino acid solution
4
Carbohydrates solution*
5
X-tra amino acids solution*
6
X-tra glutamine solution*
7
RPMI 1640 vitamins solution
8
Antibiotics solutions*
9
Hepes solution
10
Soybean Trypsin inhibitor solution*
11
Mucin solution*
12
Nucleotides solution*
13
Vitamin E solution*
14
SPIT
15
Chemically defined lipid solution (Gibco BRL)
16
Linoleic acid-oleic acid-albumin
17
Cholesterol (fresh)*
18
Hydrocortisone*
19
Prostaglandin F-2a*
* refer to Table D-2.
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452.5
5.0
2.5
5.0
2.5
2.5
10.0
3.0
5.0
0.5
5.0
0.5
0.125
1.25
2.5
0.3125
0.06125
1.25
0.5

Table D-2. Components of solutions for the preparation o f LA-3 medium
Solution
C oncentration
Component
Balanced salt buffer solution
1029.0 mg/L dH^O
1092.0 mg/L dH?0
1637.0 mg/L dH^O
599.0 mg/L dHjO
10051.7 mg/L dH^O
336.0 mg/L (IH2O

CaCfc 2 H2O
MgSO<
MgCl,. 6 H2O
KC1
NaCl
NaHCOj
Carbohydrate solution
Glucose
Trehalose
Galactose

5 .0
1 .0
1 .0

g / 1 0 0 ml
g / 1 0 0 ml
g / 1 0 0 ml

X-tra amino acid solution
Alanine
Glycine
Serine
Taurine

mg/ 1 0 0 ml
500.0 mg/100 ml
500.0 mg/100 ml
1500.0 mg/ 1 0 0 ml

Glutamine

2 0 0 0 .0

1 0 0 0 .0

X-tra glutamine solution
mg/ 1 0 0 ml

Antibiotic solutions
50.0 mg/ml
1 0 . 0 mg/ml
2 x 10' U/L

1 .0 ml o f Kanamycin stock solution
2.5 ml o f Gentamicin stock solution
2.5 ml o f Penicillin G stock solution

Soybean Trypsin inhibitor
solution
Soybean trypsin inhibitor

1 0 0 .0

mg/lOml

Mucin solution
mg/ 1 0 0 ml

Mucin

1 0 0 .0

Adenosine 5 ’-Monophosphate
Cytidine 5’-Monophosphate
Uridine 5’-Triphosphate

20.0 mg/40 ml
20.0 mg/40 ml
20.0 mg/40 ml

Nucleotide solution

Vitamin E solution
Vitamin E (a-tocopherol-acetate)

25.0 mg/ml ethanol

Cholesterol solution
Cholesterol

2 .0

mg/ml ethanol

Sterile Hydrocortisone

1 .0

mg/ml ethanol

Hydrocortisone solution
Prostaglandin F-2a
Sterile Prostaglandin

0.478 mg/ ml
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APPENDIX E ANATOMY OF AN EASTERN OYSTER

(CRASSOSTREA VIRGINICA)

Mantle
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APPENDIX F STANDARD OPERATION PROCEDURES
General cloning procedures were followed as described in the manual o f Molecular
Cloning (Sambrook et al., 1989).
C onstruction o f Plasm id pAPR/GL3E
1. The plasmid pMON 200 containing the cecropin B genomic DNA was obtained from
Dr. Jesse Jaynes, Department o f Biochemistry, Louisiana State University.
2. Primers o f CEP-1 with a Kpn I site (underlined) (5 ’-GAT-T AG-GT A-CCG-GGTGTG-GTG-TAT-TCC-TGA-CCA-AAA-A-3’) and CEP-2 with H in d m site
(underlined) (5 ’- ACT-CTT- AAG-CTT-CGT -CGA-AAT -AT A-TT A-AAT-TTT AAT-AAA-3’) were designed using PC/Gene (Intellgenetics, Mount View,
California) to amplify a 732 bp (from + 90 to - 641) fragment including 641 bp
upstream and downstream 90 bp o f transcription start site (+1) (Figure A -l).
3. The PCR products were digested with H ind IB and Kpn I restriction enzymes (New
England Biolab, Inc.), and electrophoresed in 1% agarose gel. The cecropin promoter
was recovered using a gel extraction kit (Qiagene).
4. The amplified cecropin B promoter was cloned into a pBluscript KS cloning vector
(Stratagene, La Jolla, California) for verification o f the sequence.
5. The nucleotide sequence was verified using a Cycle Sequencing Ready Reaction Kit
(Perkin Elmer, Foster City, California), and an ABI Prism™ M 310 Genetic Analyzer
(Perkin Elmer).
6. The verified cecropin B promoter sequence was released from the pBluescript KS
cloning vector using H ind III and K pn I restriction enzymes and cloned into H ind III
and Kpn I multiple cloning sites o f pGL3E containing a luciferase reporter gene.
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Figure A -1. Flow chart o f construction o f pAPR/GLE3
7. The pGL3E containing the cecropin B promoter sequence region was designated
pAPR/GL3E.
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Construction of Plasmid pPC-6
1. The restriction enzyme Bam HI was used to remove a kanamycin-resistance gene
from the TnlO cassette o f a modified mini-TnlO transposon vector derived from pNK
28S9 (Kleckner et al., 1991). Both sticky ends o f the vector were filled to form blunt
ends
2

Primers o f FISH-1 (5 ’-CGT-GCT-AGA-GGG-GGT-TTA-ACT-TT A-ATG-TTC-3 ’ )
and FISH-3 (5 ’-TCT-CCT-GAT-GTA-GTG-GCG-TGT-GGT-CGG-ATG-3 ’) were
designed using PC/Gene to amplify the 1886 bp fragment (from - 621 to +1265) o f
cecropin B genomic DNA from pMON 200.

3. The PCR products were sub-cloned into the vector above using blunt end ligation.
4. The nucleotide sequences were verified by sequencing.
5. The vector containing the correct sequences was designated as pPC-6.
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APPENDIX G UNANALYZED DATA
The raw data o f this work was organized in the spread sheet o f Microsoft Excel 2000, and
saved in a CD containing the whole electronic version o f this dissertation. The CD is
available from Dr. Richard K. Cooper and Dr. Terrence R. Tier sc h, Louisiana State
University.
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